<SEC-DOCUMENT>0001493152-25-026365.txt : 20251205
<SEC-HEADER>0001493152-25-026365.hdr.sgml : 20251205
<ACCEPTANCE-DATETIME>20251205161454
ACCESSION NUMBER:		0001493152-25-026365
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20251204
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251205
DATE AS OF CHANGE:		20251205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cycurion, Inc.
		CENTRAL INDEX KEY:			0001868419
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		ORGANIZATION NAME:           	06 Technology
		EIN:				863720717
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41214
		FILM NUMBER:		251553130

	BUSINESS ADDRESS:	
		STREET 1:		1640 BORO PLACE, FOURTH FLOOR
		CITY:			MCLEAN
		STATE:			VA
		ZIP:			22102
		BUSINESS PHONE:		888-341-6680

	MAIL ADDRESS:	
		STREET 1:		1640 BORO PLACE, FOURTH FLOOR
		CITY:			MCLEAN
		STATE:			VA
		ZIP:			22102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Western Acquisition Ventures Corp.
		DATE OF NAME CHANGE:	20210617
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:CYCU="http://cycurion.com/20251204">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_CYCU_cycurion.com_20251204 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20251204_20251204 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001868419 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000004" name="dei:EntityCentralIndexKey">0001868419</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cycu-20251204.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001868419</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-04</xbrli:startDate>
        <xbrli:endDate>2025-12-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001868419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-04</xbrli:startDate>
        <xbrli:endDate>2025-12-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001868419</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-04</xbrli:startDate>
        <xbrli:endDate>2025-12-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20251204__20251204_zgoDLbJ9x6hj"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT PURSUANT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TO
SECTION 13 OR 15(D) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <span id="xdx_907_edei--DocumentPeriodEndDate_c20251204__20251204_zvS8iuE5iCwa"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 4, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_905_edei--EntityRegistrantName_c20251204__20251204_ztLDD9G6KPJ"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000011" name="dei:EntityRegistrantName">CYCURION,
INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20251204__20251204_zDIzTe36nMk9"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityFileNumber_c20251204__20251204_zpSNbAbmt5Ai"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000013" name="dei:EntityFileNumber">001-41214</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20251204__20251204_zKcG8w0qUvs7"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000014" name="dei:EntityTaxIdentificationNumber">86-3720717</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20251204__20251204_zrzroBlVUwC"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000015" name="dei:EntityAddressAddressLine1">1640
    Boro Place</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20251204__20251204_zeVhkI43U5aa"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 420C</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityAddressCityOrTown_c20251204__20251204_z4b73ucbAgpi"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000017" name="dei:EntityAddressCityOrTown">McLean</ix:nonNumeric></span>,
    <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20251204__20251204_zHlLflPizaLk"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Virginia</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20251204__20251204_zF3NfKNBAJV6"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000019" name="dei:EntityAddressPostalZipCode">22102</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code: </b><span id="xdx_904_edei--CityAreaCode_c20251204__20251204_zC5PsdFW052b"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000020" name="dei:CityAreaCode">(310)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20251204__20251204_zB0xvgS509E9"><ix:nonNumeric contextRef="AsOf2025-12-04" id="Fact000021" name="dei:LocalPhoneNumber">740-0710</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--WrittenCommunications_c20251204__20251204_zIoEgV7EBANb"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20251204__20251204_zzei3PLNcVz4"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementTenderOffer_c20251204__20251204_zgb4exMYOqbi"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20251204__20251204_z8AZXcW5LQW1"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 51.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--Security12bTitle_c20251204__20251204__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zWA2UI7DiXgb"><ix:nonNumeric contextRef="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember" id="Fact000026" name="dei:Security12bTitle">Common
    stock, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--TradingSymbol_c20251204__20251204__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zf6En0NrtjA7"><ix:nonNumeric contextRef="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember" id="Fact000027" name="dei:TradingSymbol">CYCU</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--SecurityExchangeName_c20251204__20251204__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zgPVt6YKZGsl"><ix:nonNumeric contextRef="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
    NASDAQ Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20251204__20251204__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_zAUp5sfWpaz9"><ix:nonNumeric contextRef="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" id="Fact000029" name="dei:Security12bTitle">Redeemable
    warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--TradingSymbol_c20251204__20251204__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_z4oKKr0Y7Lc2"><ix:nonNumeric contextRef="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" id="Fact000030" name="dei:TradingSymbol">CYCUW</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--SecurityExchangeName_c20251204__20251204__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_zxPrPXa5MWVa"><ix:nonNumeric contextRef="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">The
    NASDAQ Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 51.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 51.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20251204__20251204_zSXLxSWZBVUa"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 15pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_905_edei--EntityExTransitionPeriod_c20251204__20251204_z7zOKspHPMFi"><ix:nonNumeric contextRef="AsOf2025-12-04" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 4, 2025, Cycurion, Inc. (the &#8220;Company&#8221;) and a single institutional accredited investor (the &#8220;Purchaser&#8221;)
entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which the Company agreed to sell to
the Purchaser an aggregate of 1,657,460 shares (the &#8220;Shares&#8221;) of common stock, par value $0.0001 per share, of the Company
(the &#8220;Common Stock&#8221;), or pre-funded warrants exercisable for $0.0001 per share in lieu thereof (the &#8220;Pre-Funded
Warrants&#8221;), and accompanying common warrants to purchase up to 3,314,920 shares of Common Stock (the &#8220;Warrants&#8221;) in
a private placement (the &#8220;Offering&#8221;), for gross proceeds of approximately $6 million, before deducting the placement agent&#8217;s
fees and other estimated offering expenses. The purchase price per Share (or Pre-Funded Warrant in lieu thereof) is $3.62.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants will be exercisable immediately following receipt of stockholder approval for the issuance of the Warrants and the shares of
Common Stock underlying the Warrants (the &#8220;Warrant Shares,&#8221; and such approval, &#8220;Stockholder Approval&#8221;) and have
an exercise price of $3.62 per share, subject to adjustment for customary events such as stock splits and fundamental transactions. The
Warrants will expire five years from their initial exercise date. At any time following the initial exercise date of the Warrants, the
Warrants can be exercised on a cashless basis if there is no effective registration statement registering, or no current prospectus available
for, the resale of the Warrant Shares. The Company has agreed to file a registration statement (the &#8220;Registration Statement&#8221;)
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with the U.S. Securities and Exchange Commission
(the &#8220;SEC&#8221;) covering the resale of the Shares, the shares of Common Stock underling the Pre-Funded Warrants (the &#8220;Pre-Funded
Warrant Shares&#8221;), and the Warrant Shares within 20 calendar days following the closing (the &#8220;Closing&#8221;) of the
Offering and to use commercially reasonable efforts to cause the Registration Statement to be declared effective by the SEC within
60 days following the Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement also prohibits the Company from, for 90 days following the date the Registration Statement has been declared effective:
(a) issuing, entering into any agreement to issue or announcing the issuance or proposed issuance of any shares of Common Stock
or any Common Stock Equivalents (as defined in the Purchase Agreement) or filing any registration statement other than the Registration
Statement contemplated by the Purchase Agreement, or (b) the Company or its Subsidiaries (as defined in the Purchase Agreement) effecting
or entering into any agreement to effect the issuance any shares of Common Stock or any Common Stock equivalents involving a Variable
Rate Transaction (as defined in the Purchase Agreement). In addition, the Company is required to hold a meeting of stockholders on or
prior to the date that is 90 days following the date of Closing to obtain Stockholder Approval, with the recommendation of the board
of directors of the Company that such proposals are approved; if the Company does not obtain Stockholder Approval at the first meeting,
the Company is required to call a meeting every 90 days thereafter seeking Stockholder Approval until Stockholder Approval is received
or the Warrants are no longer outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently intends to use the net proceeds from the Offering for working capital and general corporate purposes. The Closing of
the Offering occurred on December 5, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.G.P./Alliance
Global Partners (the &#8220;Placement Agent&#8221;) acted as the placement agent for the Offering. Pursuant to a placement agent
agreement (the &#8220;Placement Agent Agreement&#8221;) between the Placement Agent and the Company, dated December 4, 2025, the
Company agreed to pay the Placement Agent a cash fee equal to 10.0% of the aggregate gross proceeds raised in the Offering and a cash
fee of $500,000, and to reimburse the Placement Agent for certain reasonable, documented, and accountable expenses, including legal fees,
of $60,000 in the aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Closing, each executive officer and director of the Company has agreed entered into a lock-up agreement with
the Placement Agent pursuant to which, from the date of the Closing until 90 days following the date the Registration Statement has been
declared effective, such executive officer or director will not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose
of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position with
respect to, any shares of Common Stock of the Company or securities convertible, exchangeable or exercisable into, shares of Common Stock
of the Company beneficially owned, held or hereafter acquired by such executive officer or director, subject to customary exceptions,
or make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect
to the registration of any shares of Common Stock or Common Stock Equivalents or publicly disclose the intention to do any of the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the  Pre-Funded Warrant,  the Warrant, the Purchase Agreement and the Placement Agent Agreement
are attached hereto as Exhibits 4.1, 4.2, 10.1 and 10.2, respectively, and are incorporated herein by reference. The foregoing summaries
of the terms of the Pre-Funded Warrant, the Warrant, the Purchase Agreement and the Placement Agent
Agreement are subject to, and qualified in their entirety by, such documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained above in Item 1.01 related to the Offering, the issuance of the Shares, the issuance of the Pre-Funded Warrants,
the issuance of the Warrants, and the issuance of the Pre-Funded Warrant Shares and the Warrant Shares is hereby incorporated by reference
into this Item 3.02. The Company  issued the Shares, the Pre-Funded Warrants, the Warrants, the Pre-Funded Warrant Shares and the
Warrant Shares in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and Regulation D promulgated
thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall such securities be
offered or sold in the United States absent registration or an applicable exemption from the registration requirements and certificates
evidencing such shares contain a legend stating the same.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<i>Exhibits:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  <a href="ex4-1.htm">Pre-Funded Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm"> Securities Purchase Agreement, dated December 4, 2025, by and between the Company and the Purchaser</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Placement
    Agent Agreement, dated December 4, 2025, by and between the Company and the Placement Agent</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release dated December 4, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">99.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-2.htm">Press Release dated December 5, 2025</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
    and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Company agrees to furnish supplementally a copy
    of any omitted schedule or exhibit to the SEC upon request.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CYCURION,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    December 5, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    L. Kevin Kelly</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
    Kevin Kelly</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyFkd1qAjEQhZ/AdxgWL0WzKwr1zi4qpVoXFdvbuM7W4G5mmcS/R+pbNokVhRYaAiEz58w3k0RRK5rQWJXI8PG8mMIKq7qUFmGBBTLqHJ0ifXkdgDsX+KmMZaltuN6MKTkPOk+/3ZUuHpRHZXA7gDjpiG4n6YF4GiR9yGZRw+dT0oXaorZKliD1FjKmmhVayZdrhZU8k6bqEkhrZKNIu3JtcU1/QSLiBN7oKE/EewPTaRo1WmE1ognToXaq0dmi9k4YlVg5nLm67zt0kx+MpWqwwC1iJTclvkv2U5qRzHejM3KujA+PiecalzvJOC/c1BXppaV8P7Q/IsxY5S4Xx+2eyJCDdIbVBtlhYpEksRiK2xPdaHD6wbUAHRDwToSCGEgjGF8JqIA8YMF4LkjrHu+mR6g93YuaoQGo3ecE4x/DPrSfSV7L8oCiLYSI/2k7feC3oJYMR++F5tX9m/kNq0y+SQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(A) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Pre-Funded
WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>To
purchase Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>CYCURION,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 1,657,460 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: December 5, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
<FONT STYLE="text-transform: uppercase">Pre-Funded WARRANT to Purchase Shares of Common Stock</FONT> (the &ldquo;<U>Warrant</U>&rdquo;)
certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the &ldquo;<B>Holder</B>&rdquo;) is entitled,
upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date
hereof (the &ldquo;<B>Initial Exercise Date</B>&rdquo;) until this Warrant is exercised in full (the &ldquo;<B>Termination Date</B>&rdquo;),
but not thereafter, to subscribe for and purchase from <B>CYCURION, INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
up to 1,657,460 shares of common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;) (as subject to adjustment
hereunder, the &ldquo;<B>Warrant Shares</B>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
1</U>. <U>Definitions</U>.</B> Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), dated December 4, 2025, among the Company and the
purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
2</U></B>. <B><U>Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <B><U>Exhibit A</U></B>
(the &ldquo;<B>Notice of Exercise</B>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in <U>Section 2(d)(i)</U> herein) following the date of exercise as aforesaid, the Holder
shall deliver the aggregate Exercise Price for the number of Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in <U>Section 2(c)</U> below
is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares purchasable hereunder and the Warrant has been exercised in full, at which time the Holder shall surrender this Warrant to the
Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares purchasable hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder by the number of Warrant Shares equal to the
applicable number of Warrant Shares purchased in connection with such partial exercise. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise within one (1) Trading Day of receipt of such notice. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise
delivered on or prior to 9:00 a.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time
of execution of the Purchase Agreement, the Company agrees to deliver, or cause to be delivered, the Warrant Shares subject to such notice(s)
by 4:00 p.m. (New York City time) on the Initial Exercise Date, and the Initial Exercise Date shall be the Warrant Share Delivery Date
for purposes hereunder, <I><U>provided that</U></I> payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time will be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise
of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to
the Termination Date. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment
hereunder (the &ldquo;<B>Exercise Price</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to <U>Section 2(a)</U> hereof on a day that is not a Trading Day or (2) both executed
and delivered pursuant to <U>Section 2(a</U>) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as
defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the
Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<B>Bloomberg</B>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to <U>Section 2(a)</U> hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to <U>Section
2(a)</U> hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the VWAP of the Common Stock
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or
agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the
Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Trading Market is open for trading, including any day on which the Trading Market is open for
trading for a period of time less than the customary time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then
a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to, or resale of, the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical
delivery of the Warrant Shares, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares set forth in the Notice of Exercise to the address specified by the Holder in such Notice of Exercise by the date that
is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after
delivery of the aggregate Exercise Price to the Company, and (iii) the number of Trading Days comprising the Standard Settlement Period
after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, <I><U>provided that
</U></I>payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i)
two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of
Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;) that is a participant in the FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. Except in connection with an exercise on the Initial Exercise Date, if the Company fails to cause the Transfer
Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder
will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the Warrant Shares so purchased exceeds (y)
the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence satisfactory to the Company with respect to
the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at
law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional Warrant Shares or scrip representing fractional Warrant Shares shall be issued upon
the exercise of this Warrant. As to any fraction of a Warrant Share which the Holder would otherwise be entitled to purchase upon such
exercise, the Company shall, at its election and in lieu of the issuance of such fractional Warrant Share, either (i) pay cash in an
amount equal to such fraction multiplied by the Exercise Price or (ii) round up to the next whole Warrant Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall
be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; <I><U>provided</U></I>, <I><U>however</U></I>, that, in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, the Notice of Exercise shall be accompanied by the Assignment Form, attached hereto as <B><U>Exhibit B</U></B>,
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto and this Warrant shall be surrender to the Company and, if any portion of this Warrant remains unexercised,
a new Warrant in the form hereof shall be delivered to the assignee. The Company shall pay all Transfer Agent fees required for same-day
processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing
similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise all or any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect
to such issuance upon exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates,
(ii) any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons
whose beneficial ownership of the shares of Common Stock would or could be aggregated with the Holder&rsquo;s for the purposes of Section
13(d) (such Persons, &ldquo;<B>Attribution Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation
(as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and
its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of the Warrant Shares which would be issuable upon (i)
exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution
Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including,
without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this <U>Section 2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for
any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <U>Section 2(e)</U>, in
determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as
reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more
recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo; shall be 9.99% of the number of shares of
Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The
Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>,
<I><U>provided that</U></I> the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions
of this <U>Section 2(e)</U> shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until
the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section 2(e)</U> to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
3</U>. <U>Certain Adjustments</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which
the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant remains unchanged.
Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the record date for the determination
of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in
the case of a subdivision, combination or reclassification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<I><U>provided</U></I>, <I><U>however</U></I>,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<I><U>provided</U></I>,
<I><U>however</U></I>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the
Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such
extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion
of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of
the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of shares of Common Stock or any compulsory share exchange pursuant to which
the shares of Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the voting power of the common equity of the Company (each a &ldquo;<B>Fundamental
Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant), the number of shares of Common
Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any
limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<B>Successor Entity</B>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this <U>Section 3(e)</U> pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from
and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the
&ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume
all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share
of Common Stock, as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued
and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and
any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company declares a dividend (or any other distribution in whatever form) on the
shares of Common Stock, (B) the Company declares a special nonrecurring cash dividend on or a redemption of the shares of Common Stock,
(C) the Company authorizes the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase
any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company is required in connection
with a Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or winding up of
the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last
facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least twenty (20) calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; <I><U>provided that</U></I> the failure to deliver such notice or any defect therein or in the delivery thereof shall
not affect the validity of the corporate action required to be specified in such notice and <I><U>provided, further that</U></I> no notice
shall be required if the information is disseminated in a press release or document filed with the Commission. To the extent that any
notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time while
this Warrant is outstanding, reduce the then-current Exercise Price to any amount and for any period of time deemed appropriate by the
board of directors of the Company in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
4</U>. <U>Transfer of Warrant</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
as Exhibit B duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance
date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
5</U>. <U>Miscellaneous</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U> herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares underlying this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued, and the Warrant Shares, delivered, as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock
may be listed. The Company covenants that all Warrant Shares underlying this Warrant, which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with
such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any shares of Common Stock above the amount payable therefor upon such
exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant and (iii)
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any share of Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYCURION,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>L.
    Kevin Kelly</I></FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
    Kevin Kelly</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO:
CYCURION<FONT STYLE="font-variant: small-caps">, INC.</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in lawful money
    of the United States; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if permitted the cancellation
    of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
    with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection
    2(c).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant Shares shall be delivered to
    the following DWAC Account Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
    OF HOLDER]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ ____, _______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(A) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>CYCURION,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 3,314,920 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: December 5, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, Armistice Capital Master Fund
Ltd. or its assigns (the &ldquo;<B>Holder</B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and
the conditions hereinafter set forth, at any time or times on or after the date hereof (the &ldquo;<B>Initial Exercise Date</B>&rdquo;)
and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date (the &ldquo;<B>Termination
Date</B>&rdquo;) but not thereafter, to subscribe for and purchase from <B>CYCURION, INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
up to 3,314,920  shares of common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;) (as subject
to adjustment hereunder, the &ldquo;<B>Warrant Shares</B>&rdquo;). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
1</U>. <U>Definitions</U>.</B> Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth
in that certain Securities Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), dated December 4, 2025, between the
Company and each purchaser signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
2</U>. <U>Exercise</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <B><U>Exhibit A</U></B>
(the &ldquo;<B>Notice of Exercise</B>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in <U>Section 2(d)(i)</U> herein) following the date of exercise as aforesaid, the Holder
shall deliver the aggregate Exercise Price for the number of Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in <U>Section 2(c)</U> below
is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, at which time, the Holder shall surrender this Warrant to the
Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares purchasable hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder by the number of Warrant Shares equal to the
applicable number of Warrant Shares purchased in connection with such partial exercise. <B>The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $3.62, subject to adjustment hereunder
(the &ldquo;<B>Exercise Price</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. Notwithstanding anything to the contrary set forth herein, if at the time of exercise hereof there is no effective
registration statement registering, or the prospectus contained therein is not available for the issuance of, the Warrant Shares to the
Holder, then this Warrant may only be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to <U>Section 2(a)</U> hereof on a day that is not a Trading Day or (2) both executed
and delivered pursuant to <U>Section 2(a)</U> hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as
defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the
Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<B>Bloomberg</B>&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to <U>Section 2(a)</U> hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to <U>Section
2(a)</U> hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
<U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the VWAP of the Common Stock
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for
trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or
agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the
Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Trading Market is open for trading, including any day on which the Trading Market is open for
trading for a period of time less than the customary time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted to
the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by
Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule
144 (assuming cashless exercise of the Warrant), and otherwise by physical delivery of the Warrant Shares, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares set forth in the Notice of Exercise to the
address specified by the Holder in such Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery
to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company, and
(iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
(such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, <I><U>provided that</U></I> payment of the aggregate Exercise Price (other
than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth
Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares
are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;)
that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. <B>The Holder and any
assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase
of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time will be
less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the Warrant Shares so purchased exceeds (y)
the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence satisfactory to the Company with respect to
the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at
law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional Warrant Shares or scrip representing fractional Warrant Shares shall be issued upon
the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise,
the Company shall, at its election and in lieu of the issuance of such fractional Warrant Share, either (i) pay cash in an amount equal
to such fraction multiplied by the Exercise Price or (ii) round up to the next whole Warrant Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall
be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; <I><U>provided</U></I>, <I><U>however</U></I>, that, in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, the Notice of Exercise shall be accompanied by the Assignment Form, attached hereto as <B><U>Exhibit B</U></B>,
duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto and this Warrant shall be surrendered to the Company and, if any portion of this Warrant remains
unexercised, a new Warrant in the form hereof shall be delivered to the assignee. The Company shall pay all Transfer Agent fees required
for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise all or any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect
to such issuance upon exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates,
(ii) any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons
whose beneficial ownership of the shares of Common Stock would or could be aggregated with the Holder&rsquo;s for the purposes of Section
13(d) (such Persons, &ldquo;<B>Attribution Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation
(as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and
its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of the Warrant Shares which would be issuable upon (i)
exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution
Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including,
without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this <U>Section 2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for
any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <U>Section 2(e)</U>, in
determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as
reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more
recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant. The Holder,
upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this <U>Section 2(e)</U>, <I><U>provided
that</U></I> the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately
after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this <U>Section
2(e)</U> shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the sixty-first (61<SUP>st</SUP>)
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this <U>Section 2(e)</U> to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
3</U>. <U>Certain Adjustments</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which
the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant remains unchanged.
Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the record date for the determination
of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in
the case of a subdivision, combination or reclassification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
RESERVED.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to
the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<I><U>provided</U></I>, <I><U>however</U></I>,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<I><U>provided</U></I>,
<I><U>however</U></I>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the
Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such
extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion
of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of
the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of shares of Common Stock or any compulsory share exchange pursuant to which
the shares of Common Stock are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the voting power of the common equity of the Company (each a &ldquo;<B>Fundamental
Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant), the number of shares of Common
Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of
shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any
limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise
Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty (30) days
after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental
Transaction), purchase this Warrant from the Holder by paying to the Holder, as described below, an amount of consideration equal to
the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such
Fundamental Transaction, <I><U>provided</U></I>, <I><U>however</U></I>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, Holder shall only be entitled to receive from the Company
or any Successor Entity, as of the date of the consummation of such Fundamental Transaction the same type or form of consideration (and
in the same proportion), valued at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid
to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; <I><U>provided further</U></I>, that if holders of Common Stock
of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed
to have received shares of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in
such Fundamental Transaction. &ldquo;Black Scholes Value&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<B>Bloomberg</B>&rdquo;) determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction
and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined
utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash,
if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (D) a remaining option
time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date
and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within
five Business Days of the Holder&rsquo;s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall
cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this <U>Section 3(e)</U> pursuant to written agreements in form and substance reasonably satisfactory to the Holder
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share
of Common Stock, as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued
and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and
any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company declares a dividend (or any other distribution in whatever form) on the
shares of Common Stock, (B) the Company declares a special nonrecurring cash dividend on or a redemption of the shares of Common Stock,
(C) the Company authorizes the granting to all holders of the shares of Common Stock rights or warrants to subscribe for or purchase
any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company is required in connection
with a Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or winding up of
the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last
facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of
the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)
the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close,
and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of Common
Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
<I><U>provided that</U></I> the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the
validity of the corporate action required to be specified in such notice and <I><U>provided, further that</U></I> no notice shall be
required if the information is disseminated in a press release or document filed with the Commission. To the extent that any notice provided
in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time while
this Warrant is outstanding, reduce the then-current Exercise Price to any amount and for any period of time deemed appropriate by the
board of directors of the Company in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
4</U>. <U>Transfer of Warrant</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth herein, this Warrant and
all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of
this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially
in the form attached hereto as <B><U>Exhibit B</U></B> duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance
date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
5</U>. <U>Miscellaneous</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U> herein, in
no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares underlying this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued, and the Warrant Shares, delivered, as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock
may be listed. The Company covenants that all Warrant Shares underlying this Warrant, which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with
such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any shares of Common Stock above the amount payable therefor upon such
exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant and (iii)
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any share of Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYCURION,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>L.
    Kevin Kelly</I></FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
    Kevin Kelly</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<FONT STYLE="text-transform: uppercase">CYCURION, INC.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    lawful money of the United States; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
    &nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
    2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
    procedure set forth in subsection 2(c).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
    OF HOLDER]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity:</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ ____, _______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of December 4, 2025, between Cycurion, Inc., a
Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below)
and Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not
jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(qq).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Authorizations</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(qq).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors, or any authorized committee thereof, of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1st) Trading
Day following the date hereof if this Agreement is entered into before 4:00 p.m. Eastern time, or no later than the second (2nd) Trading
Day following the date hereof, if this Agreement is entered at or after 4:00 p.m. Eastern time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means the common warrants to purchase shares of Common Stock delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, in substantially the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Seward &amp; Kissel LLP, One Battery Park Plaza, New York, New York 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company&rsquo;s
knowledge</U>&rdquo; or words of similar import mean the actual knowledge of any executive officer (as defined in Rule 405 under the
Securities Act) of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disqualification
Event</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>DVP</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>DWAC</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EDGAR</U>&rdquo;
means the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval System.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission,
(b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale
restrictions, (c) following the one year anniversary of the Closing Date provided that a holder of Shares or Warrant Shares is not an
Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under the
Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written opinion
that resales may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form
and substance reasonably acceptable to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Environmental
Law</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(t).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, options, restricted stock units, or other equity awards to employees,
consultants, contractors, advisors, officers, or directors of the Company pursuant to any equity incentive plan duly adopted for such
purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee
directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion
of any Securities issued hereunder and upon exercise of other securities exercisable or exchangeable for or convertible into shares of
Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date
of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of
such securities (other than in connection with stock splits, combinations or pursuant to the terms of any anti-dilution provision in
any existing agreement or security) or to extend the term of such securities, (c) shares of Common Stock or securities exercisable or
exchangeable for or convertible into shares of Common Stock sold to employees, directors, consultants, or any of their affiliated entities
in the ordinary course of business or pursuant to agreements or in connection with commitments in place as of the date hereof, and (d)
securities issued pursuant to acquisitions, joint ventures, strategic alliances, or other strategic transactions, including without limitation
collaborations or arrangements involving research and development or the sale or licensing of intellectual property, approved by a majority
of the disinterested directors of the Company, except for a transaction in which the Company is issuing securities primarily for the
purpose of raising capital or to an entity whose primary business is investing in securities (for avoidance of doubt, securities issued
to a venture arm of a strategic investor shall be deemed an &ldquo;Exempt Issuance&rdquo;), provided in the case of each of clauses (c)
and (d) (other than, with respect to clause (d), for commitments in place as of the date hereof), that such securities are issued as
&ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any
registration statement in connection therewith during the prohibition period in Section 4.12(a) herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FINRA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Hazardous
Substances</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(dd).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(q).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Covered Person</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>IT
Systems</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lien</U>&rdquo;
means a lien, charge, mortgage, pledge, security interest, claim, right of first refusal, pre-emptive right, or other encumbrance of
any kind whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the lock-up agreements, each dated as of the Closing Date in substantially the form of <U>Exhibit A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Money
Laundering Laws</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(oo).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>OFAC</U>&rdquo;
means the Office of Foreign Assets Control of the U.S. Treasury Department.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offering</U>&rdquo;
means the offering of the Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Pre-Funded Warrant Purchase Price</U>&rdquo; means the Per Share Purchase Price minus $0.0001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $3.62, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Personal
Data</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent, dated as
of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means A.G.P./Alliance Global Partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in
accordance with Section 2.3(a) hereof, in substantially the form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition) pending or, to the Company&rsquo;s knowledge, threatened in writing against the Company, a Subsidiary or any of
their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal,
state, county, local or foreign).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; shall have the meaning ascribed to such term in Section 4.19.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Restriction
Period</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Sanctions</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(kk).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means for each Purchaser, the Shares, the Warrants and the Warrant Shares purchased pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or
any successor entity) from the stockholders of the Company with respect to the Common Warrants and the Common Warrant Shares issuable
upon the exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares or Pre-Funded Warrants (in lieu of Shares)
and Common Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next
to the heading &ldquo;Subscription Amount,&rdquo; in U.S. dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
and &ldquo;<U>Subsidiaries</U>&rdquo; means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable,
also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means The Nasdaq Stock Market LLC (or any nationally recognized successor thereto); provided, however, that in the
event the Company&rsquo;s Common Stock is ever listed or traded on The Nasdaq Global Market, The Nasdaq Global Select Market, The New
York Stock Exchange, NYSE American, NYSE Arca, the OTC Bulletin Board, or the OTCQX or the OTCQB operated by the OTC Markets Group, Inc.
(or any nationally recognized successor to any of the foregoing), then the &ldquo;Trading Market&rdquo; shall mean such other market
or exchange on which the Company&rsquo;s Common Stock is then listed or traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants and the Lock-Up Agreements, all exhibits and schedules thereto and hereto and
any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the Common Warrant Shares and the Pre-Funded Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and each Purchaser, severally
and not jointly, agrees to purchase, (i) the number of shares of Common Stock set forth under the heading &ldquo;Subscription Amount&rdquo;
on the Purchaser&rsquo;s signature page hereto, at the Per Share Purchase Price, and (ii) Common Warrants exercisable for shares of Common
Stock as calculated pursuant to Section 2.2(a). Notwithstanding anything herein to the contrary, to the extent that a Purchaser determines,
in its sole discretion, that as a result of such Purchaser&rsquo;s Subscription Amount, such Purchaser (together with such Purchaser&rsquo;s
Affiliates and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially
own shares of Common Stock in excess of the Beneficial Ownership Limitation, the Purchaser may elect to purchase Pre-Funded Warrants
in lieu of the Shares as determined pursuant to Section 2.3(a). The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99%
(or, at the election of the Purchaser, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to
the issuance of the Securities on the Closing Date. In each case, the election to receive Pre-Funded Warrants is solely at the option
of the Purchaser; provided, however, the Purchaser shall receive Pre-Funded Warrants at the option of the Company if necessary to avoid
a stockholder vote in connection with the purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Purchaser shall deliver to the Placement Agent (or its clearing firm), via wire transfer, immediately available funds equal to such Purchaser&rsquo;s
Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for Delivery Versus
Payment (&ldquo;<U>DVP</U>&rdquo;) settlement with the Company or its designees. The Company shall deliver to each Purchaser its respective
Shares and Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing
shall occur remotely via the exchange of documents and signatures or such other location as the parties shall mutually agree. Unless
otherwise directed by the Placement Agent, settlement of the Shares shall occur via DVP (<I>i.e.</I>, on the Closing Date, the Company
shall issue the Shares in book-entry form registered in the Purchasers&rsquo; names and addresses and payment therefor shall be made
by the Placement Agent (or its clearing firm) by wire transfer to the Company). Unless otherwise directed by the Placement Agent, the
Warrants shall be issued to each Purchaser in originally signed form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel in a form reasonably acceptable to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Company&rsquo;s wire instructions, on Company letterhead and executed by the Company&rsquo;s Chief Executive Officer or Chief Financial
Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
subject to the penultimate sentence of Section 2.1(a), a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer
Agent to deliver on an expedited basis, in book entry form (unless otherwise requested by the Purchasers), Shares equal to the number
of shares of Common Stock set forth on such Purchaser&rsquo;s signature page hereto, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
an originally signed Common Warrant registered in the name of such Purchaser to purchase up to the number of shares of Common Stock equal
to 200% of such Purchaser&rsquo;s Shares plus the Pre-funded Warrant Shares underlying such Purchaser&rsquo;s Pre-Funded Warrant on the
date hereof, with an exercise price equal to $3.62, subject to adjustment as set forth therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
if applicable, an originally signed Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares
of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants divided by the Per
Pre-Funded Warrant Purchase Price, with an exercise price equal to $0.0001, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
Lock-up Agreements, in substantially in the form attached hereto as <U>Exhibit A</U>, executed by each of the Company&rsquo;s executive
officers and directors as of the date hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
an Officer&rsquo;s Certificate, in form and substance reasonably satisfactory to the Placement Agent; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
a Secretary&rsquo;s Certificate, in form and substance reasonably satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount, which shall be made available for DVP settlement with the Company or its designees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect (as defined below), in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers
contained herein (unless as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent
representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Trading
Market on which it is currently listed, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported
by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by U.S. or New York State authorities,
nor shall there have occurred after the date of this Agreement any material outbreak or escalation of hostilities or other national or
international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case,
in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser
in addition to the information included in the Disclosure Schedules attached hereto and SEC Reports, which Disclosure Schedules and SEC
Reports shall be deemed a part hereof and shall qualify any representation or warranty made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules or in the SEC Reports:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company (each, a &ldquo;<U>Subsidiary</U>&rdquo;, and collectively,
the &ldquo;<U>Subsidiaries</U>&rdquo;) are as set forth in the SEC Reports. Except as disclosed in <U>Schedule 3.1(a)</U> or in the SEC
Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens (other than pledges of the capital stock or other equity interests of such Subsidiaries to secure indebtedness described
in the SEC Reports), and all of the issued and outstanding shares of capital stock or equity interests, as applicable, of each Subsidiary
are validly issued and are fully paid, non-assessable and free of preemptive rights. There are no outstanding options, warrants, scrips
or rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any capital stock or equity interests,
as applicable, of any Subsidiary, or contracts, commitments, understandings or arrangements by which any Subsidiary is or may become
bound to issue capital stock or equity interests, as applicable. If the Company has no Subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. Each of the Company and the Subsidiaries has been duly organized and, except as set forth in <U>Schedule
3.1(b)</U>, validly exists as a corporation, limited partnership or company in good standing (or the foreign equivalent thereof, if any)
under the laws of its jurisdiction of organization. The Company and each of the Subsidiaries is duly qualified to do business and is
in good standing as a foreign or extra-provincial corporation, partnership, company or limited liability company in each jurisdiction
in which the character or location of its properties (owned, leased or licensed) or the nature or conduct of its business makes such
qualification necessary, except for those failures to be so qualified or in good standing which (individually and in the aggregate) would
not have a Material Adverse Effect. No Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification. Neither the Company nor any Subsidiary is in violation nor default
of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents,
except for those violations or failures which (individually and in the aggregate) would not have a Material Adverse Effect. The term
&ldquo;<U>Material Adverse Effect</U>&rdquo; means a material adverse effect on (i) the business, general affairs, management, condition
(financial or otherwise), results of operations, stockholders&rsquo; equity, assets, properties or prospects of the Company and the Subsidiaries,
taken as a whole, (ii) the legality, validity or enforceability of any Transaction Document, or (iii) the Company&rsquo;s ability to
perform in any material respect on a timely basis its obligations under any Transaction Document; <U>provided, however</U>, that in no
event shall any of the following effects after the date hereof, alone or in combination with one another, be deemed to constitute, a
Material Adverse Effect: (1) any effect resulting directly or indirectly from general business or economic conditions, except to the
extent such general business or economic conditions have a materially disproportionate effect on the Company as compared to companies
in the Company&rsquo;s industry, (2) any change in the Company&rsquo;s stock price or trading volume in and of itself (but not the underlying
causes thereof), or (3) any effect caused by the announcement or pendency of the transactions contemplated by the Transaction Documents,
or the identity of any Purchaser or any of its affiliates as the purchaser in connection with the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors, or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals (as defined below). This Agreement and each other Transaction Document to which
the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights, (ii) as limited by general equitable principles
and laws relating to the availability of specific performance, injunctive relief or other equitable remedies, and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) filings with the Commission pursuant to Sections 4.19 of this Agreement, (iii)
the notice and/or application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon
in the time and manner required thereby, (iv) the filing of a Form D with the Commission, (v) filings required by the Financial Industry
Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;), (vi) such filings as are required to be made under applicable state securities laws,
(vii) the Stockholder Approval, and (viii) such consents, waivers, and authorizations that shall be obtained prior to Closing (collectively,
the &ldquo;<U>Required Approvals</U>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Shares and Warrant Shares</U>. The Shares and Warrant Shares are duly authorized and, when issued and paid for in
accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company. The Warrants are duly authorized and, when issued in accordance with the terms of this agreement, will
be duly and validly issued and free and clear of all Liens imposed by the Company. The Company has reserved, or will have reserved by
the time of Closing, from its duly authorized capital stock the maximum number of shares of Common Stock currently issuable pursuant
to this Agreement and the Warrants, except as otherwise permitted by the terms of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization.</U> The equity capitalization of the Company as of the date hereof is set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. All of the issued and outstanding shares of Common Stock are fully paid and non-assessable and have been duly and
validly authorized and issued, in compliance with all applicable federal and state securities laws and not in violation of or subject
to any preemptive or similar right that entitles any person to acquire from the Company any Common Stock or other security of the Company
or any security convertible into, or exercisable or exchangeable for, Common Stock or any other such security, except for such rights
as may have been fully satisfied or waived prior to the date hereof. Except as set forth in the SEC Reports or on <U>Schedule 3.1(g)</U>,
or as a result of the issuance and sale of the Securities, the Company has not issued any capital stock since its most recently filed
SEC Report, except pursuant to existing Company stock option or omnibus incentive plans. Except as set forth in the SEC Reports or on
<U>Schedule 3.1(g)</U>, or as a result of the issuance and sale of the Securities or issuances pursuant to existing Company stock option
or omnibus incentive plans, the Company has no outstanding options, warrants, scrips or rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any Common Stock, or contracts, commitments, understandings or arrangements
by which the Company is or may become bound to issue additional Common Stock or Common Stock Equivalents and no Person has any right
of first refusal, pre-emptive right, right of participation, or any similar right to participate in the transactions contemplated by
the Transaction Documents, except for such rights as may have been fully satisfied or waived prior to the date hereof. Except as set
forth in the SEC Reports or on <U>Schedule 3.1(g)</U>, the issuance and sale of the Securities will not obligate the Company to issue
Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under any of such securities. Except as set forth in the SEC Reports, there
are no outstanding securities or instruments of the Company with any provision that adjusts the exercise, conversion, exchange or reset
price of such security or instrument upon an issuance of securities by the Company (other than in connection with a stock split, recapitalization,
or similar transaction). Except as set forth in the SEC Reports, there are no outstanding securities or instruments of the Company that
contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company
is or may become bound to redeem an equity security of the Company. The Company does not have any stock appreciation rights or &ldquo;phantom
share&rdquo; plans or agreements or any similar plan or agreement. Except as set forth in the SEC Reports, there are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two (2) years preceding the
date hereof (or such shorter period as the Company was required by law or regulation to file such materials) (the foregoing materials,
including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<U>SEC
Reports</U>&rdquo;). None of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Financial Statements</U>. The consolidated financial statements of the Company, including the notes thereto, included or incorporated
by reference in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with accounting principles generally accepted in the United States (&ldquo;<U>GAAP</U>&rdquo;) applied on a consistent basis during the
periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial
statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the
Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest consolidated financial statements
included in or incorporated by reference into the SEC Reports, except as set forth in the SEC Reports, (i) there has been no event, occurrence
or development that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) neither the Company nor
any Subsidiary has incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in
the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s
financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method
of accounting in any material respect, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company
has not issued any equity securities to any executive officer, director or Affiliate, except pursuant to existing Company stock option
or omnibus incentive plans. The Company does not have pending before the Commission any request for confidential treatment of information.
Except for the issuance of the Securities contemplated by this Agreement, no material event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or
their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one (1) Trading Day prior to the date that this representation is made or will be publicly disclosed in the SEC Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Litigation</U>. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, Proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;) that (i) adversely affects or challenges the legality, validity or enforceability of any
of the Transaction Documents or the Securities or (ii) would, if there were an unfavorable decision, have or reasonably be expected to
result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or executive officer thereof, is, or has
been during the last three years, the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty, which could result in a Material Adverse Effect. There has not been during the last three
years, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company
or any current or former director or executive officer of the Company. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement. To the knowledge of the Company, no executive
officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the
Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are
in compliance with all applicable U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices,
terms and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), except in each case as set forth in the SEC Reports, (ii) is in violation
of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is, or has been during the last three
years, in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign,
federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety
and employment and labor matters, in each case that is applicable to the Company, except in each case of (i), (ii) and (iii) as would
not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Environmental Law</U>. There has been no storage, generation, transportation, handling, use, treatment, disposal, discharge, emission,
contamination, release or other activity involving any kind of hazardous, toxic or other wastes, pollutants, contaminants, petroleum
products or other hazardous or toxic substances, chemicals or materials (&ldquo;<U>Hazardous Substances</U>&rdquo;) by, due to, on behalf
of, or caused by the Company or any Subsidiary (or, to the Company&rsquo;s knowledge, any other entity for whose acts or omissions the
Company is or may be liable) upon any property now or previously owned, operated, used or leased by the Company or any Subsidiary, or
upon any other property, that would be a violation of or give rise to any liability under any applicable law, rule, regulation, order,
judgment, decree or permit, common law provision or other legally binding standard relating to pollution or protection of human health
and the environment (&ldquo;<U>Environmental Law</U>&rdquo;), except for violations and liabilities which, individually or in the aggregate,
would not have a Material Adverse Effect. There has been no disposal, discharge, emission contamination or other release of any kind
at, onto or from any such property or into the environment surrounding any such property of any Hazardous Substances with respect to
which the Company or any Subsidiary has knowledge, except as would not, individually or in the aggregate, have a Material Adverse Effect.
There is no pending or, to the best of the Company&rsquo;s knowledge, threatened administrative, regulatory or judicial action, claim
or notice of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any Subsidiary,
except as would not, individually or in the aggregate, have a Material Adverse Effect. To the best of the Company&rsquo;s knowledge,
no property of the Company or any Subsidiary is subject to any Lien under any Environmental Law, except as would not, individually or
in the aggregate, have a Material Adverse Effect. Except as disclosed in the SEC Reports, neither the Company nor any Subsidiary is subject
to any order, decree, agreement or other individualized legal requirement related to any Environmental Law, that, in any case (individually
or in the aggregate), would have a Material Adverse Effect. The Company and each Subsidiary has all permits, authorizations and approvals
required under any applicable Environmental Laws and are each in compliance with their requirements, except as would not, individually
or in the aggregate, have a Material Adverse Effect. In the ordinary course of its business, the Company periodically reviews the effect
of Environmental Laws on the business, operations and properties of the Company and the Subsidiaries and identifies and evaluates associated
costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up, closure or remediation
of properties or compliance with Environmental Laws, or any permit, license or approval, any related constraints on operating activities
and any potential liabilities to third parties). On the basis of such review, the Company has reasonably concluded that such associated
costs and liabilities would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except (i) such as would not reasonably be expected to have a Material Adverse Effect, (ii)
Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP
and, the payment of which is neither delinquent nor subject to penalties, and (iii) Liens securing indebtedness described in the SEC
Reports. Any real property and facilities currently held under lease by the Company and the Subsidiaries are held by them under valid,
subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects, except where
the failure to so comply would not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Intellectual Property</U>. To the Company&rsquo;s knowledge, the Company and the Subsidiaries have, or have rights to use (or can
acquire on reasonable terms), all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade
secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in
connection with their respective businesses as described in the SEC Reports and which the failure to so have could reasonably be expected
to have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement except
as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the
date of the latest financial statements included within or incorporated by reference into the SEC Reports, a written notice of a claim
or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person or is aware of
any facts which would form a reasonable basis for any such claim, except as would not have or reasonably be expected to not have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. None of the Intellectual Property Rights used by the Company
or any of its Subsidiaries in their respective businesses has been obtained or is being used by the Company or such Subsidiary in violation
of any contractual obligation binding on the Company or any of its subsidiaries in violation of the rights of any person. The Company
and its subsidiaries have taken all reasonable steps in accordance with normal industry practice to protect and maintain the Intellectual
Property Rights including, without limitation, the execution of appropriate nondisclosure and invention assignment agreements. The consummation
of the transactions contemplated by this Agreement will not result in the loss or impairment of, or payment of, and additional amounts
with respect to, nor require the consent of, any other person regarding the Company&rsquo;s or any of its subsidiaries&rsquo; right to
own or use any of the Intellectual Property Rights as owned or used in the conduct of such party&rsquo;s business as currently conducted.
To the knowledge of the Company and its Subsidiaries, no employee of any of the Company or its subsidiaries is the subject of any pending
claim or proceeding involving a violation of any term of any employment contract, invention disclosure agreement, patent disclosure agreement,
noncompetition agreement, non-solicitation agreement, nondisclosure agreement or restrictive covenant to or with a former employer, where
the basis of such violation relates to such employee&rsquo;s employment with the Company or its subsidiaries or actions undertaken by
the employee while employed with the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as the Company believes are prudent and customary in the businesses in which the Company and the Subsidiaries
are engaged, including, but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the executive officers or directors
of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, executive officers and directors),
including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to
or from any executive officer, director or such employee or, to the knowledge of the Company, any entity in which any executive officer,
director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each
case in excess of $120,000 other than for (i) payment of compensation for services rendered, (ii) reimbursement for expenses incurred
on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option or omnibus incentive
plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with
all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, except as disclosed in the SEC Reports. The Company and the
Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are
executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the
Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the
disclosure controls and procedures of the Company and the Subsidiaries as of applicable dates specified under the Exchange Act (such
date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Except as set forth in the SEC Reports, since the Evaluation Date, there have been no changes in the internal
control over financial reporting (as such term is defined in the Exchange Act) of the Company and the Subsidiaries that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and the Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Certain Fees</U>. Except for fees payable to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be
payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. Other than to Persons engaged by any
Purchaser, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other
Persons for fees of type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company</U>. The Company is not, and immediately after receipt of payment for the Securities, will not be required to register
as an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct
its business in a manner so that it will not be required to register as an &ldquo;investment company&rdquo; subject to registration under
the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Except as set forth in the SEC Reports, and except as set forth in this Agreement, no Person has any right
to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary
that has not been satisfied or waived prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered with the Commission under Section 12(b) the Exchange Act.
The Company has not received any notice from the Commission that it is contemplating terminating such registration. Except as set forth
in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Common Stock is currently eligible for electronic transfer through The Depository Trust Company
or another established clearing corporation and the Company is current in payment of the fees to The Depository Trust Company (or such
other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its jurisdiction of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the
Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result
of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information that is not otherwise
disclosed in the SEC Reports. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting
transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding
the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including pursuant to the SEC
Reports and the Disclosure Schedules to this Agreement, is true and correct in all material respects and does not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light
of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve (12)
months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under
which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act, or (ii) except as set forth in the SEC Reports,
any applicable stockholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Solvency</U>. Except as set forth in the SEC Reports, based on the consolidated financial condition of the Company as of the Closing
Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable
value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing
debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute
unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking
into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements
and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive,
were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts
on or in respect of its liabilities when such amounts are required to be paid. Except as set forth in the SEC Reports, the Company does
not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to
be payable on or in respect of its debt). Except as set forth in the SEC Reports, the Company has no knowledge of any facts or circumstances
that lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one (1) year from the Closing Date. All outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for
which the Company or any Subsidiary has commitments, is set forth in the SEC Reports or on <U>Schedule 3.1(dd)</U>. For the purposes
of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000
(other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases
required to be capitalized in accordance with GAAP. Except as set forth in the SEC Reports, neither the Company nor any Subsidiary is
in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Tax Status.</U> Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all U.S. federal, state and local income and all
foreign tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
, other than those being contested in good faith and for which adequate reserves have been provided and (iii) has set aside on its books
provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Foreign Corrupt Practices; Criminal Acts.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Accountants</U>. The Company&rsquo;s independent registered public accounting firm is as set forth in the SEC Reports. To the knowledge
and belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities.</U> The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(e) and 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future securities offering transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities (in material compliance with applicable laws) at various times during the period that the Securities are outstanding,
and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at
and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities
do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf (other than the Placement Agent,
as to which no representation is made) has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid
for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person
any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and
(iii), compensation paid to the Placement Agent pursuant to the Placement Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any &ldquo;<U>Sanctions</U>,&rdquo; which
shall include but are not limited to any U.S. sanctions administered by the OFAC and the Company will not, directly or indirectly, use
the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture
partner or other person or entity, for the purpose of financing the activities of any person currently subject to any Sanctions, including
but not limited to U.S. sanctions administered by OFAC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Stock Option and Omnibus Incentive Plans.</U> Each stock option granted by the Company under the Company&rsquo;s stock option or omnibus
incentive plan, or as an inducement grant outside of such plan, was granted (i) in accordance with the terms of such plan, or under its
terms, respectively, and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock
option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option or omnibus
incentive plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or the Subsidiaries or their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the U.S. Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five
percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in
all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company
or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Information Technology</U>. The Company&rsquo;s and the Subsidiaries&rsquo; information technology assets and equipment, computers,
systems, networks, hardware, software, websites, applications, and databases (collectively, &ldquo;<U>IT Systems</U>&rdquo;) operate
and perform in all material respects as required in connection with the operation of the business of the Company and the Subsidiaries
as currently conducted. The Company and the Subsidiaries maintain commercially reasonable controls, policies, procedures, and safeguards
to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and all personal, personally identifiable, sensitive, confidential or regulated data (&ldquo;<U>Personal Data</U>&rdquo;)
processed and stored thereon, and to the knowledge of the Company, there have been no breaches, incidents, violations, outages, compromises
or unauthorized uses of or accesses to same, except as would not reasonably be expected to have a Material Adverse Effect. The Company
and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices, and are
presently in compliance in all material respects with all applicable laws or statutes and all applicable judgments, orders, rules and
regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating
to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized
use, access, misappropriation or modification, except for any such noncompliance that would not reasonably be expected to have a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Regulatory</U>. Except as described in the SEC Reports, the Company and its Subsidiaries (i) are and at all times have been in material
compliance with all statutes, rules and regulations applicable to the Company and all other local, state, federal, national, supranational
and foreign laws, manual provisions, policies and administrative guidance relating to the regulation of the Company (collectively, the
&ldquo;<U>Applicable Laws</U>&rdquo;) except for such noncompliance which in the aggregate would not reasonably be expected to have a
Material Adverse Effect; (ii) have not received any notice from any court or arbitrator or governmental or regulatory authority or third
party alleging or asserting noncompliance with any Applicable Laws or any licenses, exemptions, certificates, approvals, clearances,
authorizations, permits, registrations and supplements or amendments thereto required by any such Applicable Laws (&ldquo;<U>Authorizations</U>&rdquo;);
(iii) possess all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation
of any term of any such Authorizations; (iv) have not received written notice of any claim, action, suit, proceeding, hearing, enforcement,
investigation arbitration or other action from any court arbitrator or governmental or regulatory authority or third party alleging that
any product operation or activity is in violation of any Applicable Laws or Authorizations nor is any such claim, action, suit, proceeding,
hearing, enforcement, investigation, arbitration or other action overtly threatened; (v) have not received any written notice that any
court or arbitrator or governmental or regulatory authority has taken, is taking or intends to take, action to limit, suspend, materially
modify or revoke any Authorizations nor is any such limitation, suspension, modification revocation overtly threatened; (vi) have filed,
obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements
or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments were complete and accurate in all material respects on the date field (or
were corrected or supplemented by a subsequent submission); and (vii) are not a party to any corporate integrity agreements, monitoring
agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;Issuer Covered Person&rdquo;) is subject to any of the
&ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<U>Disqualification
Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care
to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable,
with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person it becomes aware of and (ii) any event it becomes aware
of that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof
or thereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its
terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other
laws of general application affecting enforcement of creditors&rsquo; rights generally; (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as
defined in Rule 144A(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>General Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the reports filed with the Commission, including the SEC Reports, and has been afforded: (i)
the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning
the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities and all such questions
asked have been answered to its satisfaction; (ii) access to information about the Company and its financial condition, results of operations,
business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain
such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make
an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent,
nor any Affiliate of the Placement Agent, has provided such Purchaser with any information or advice with respect to the Securities nor
is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent, nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against, or a prohibition
of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability of, and/or securing of, securities
of the Company in order for such Purchaser (or its broker or other financial representative) to effect Short Sales or similar transactions
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Voting Agreements</U>. The Purchaser is not a party to any agreement or arrangement, whether written or oral, between the Purchaser
and any other Purchaser and any of the Company&rsquo;s stockholders as of the date hereof, regulating the management of the Company,
the stockholders&rsquo; rights in the Company, the transfer of shares in the Company, including any voting agreements, stockholder agreements
or any other similar agreement, even if its title is different or has any other relations or agreements with any of the Company&rsquo;s
stockholders, directors or officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Brokers</U>. No agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority
of the Purchaser is or will be entitled to any broker&rsquo;s or finder&rsquo;s fee or any other commission or similar fee, directly
or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement,
any of the transactions contemplated by this Agreement, or on account of any action taken by the Purchaser in connection with the transactions
contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Independent Advice</U>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf
of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Private Placement</U>. Each Purchaser understands and acknowledges that the Company is offering and selling the Securities in reliance
upon an exemption from the registration requirements of the Securities Act provided by Section 4(a)(2) and Regulation D under the Securities
Act and that the Securities are &ldquo;restricted securities&rdquo; within the meaning of Rule 144(a)(3) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Restricted Securities</U>. Each Purchaser understands and acknowledges that the Securities have not been and will not be registered
under the Securities Act or with any state or other jurisdiction of the United States, nor approved or disapproved by the Securities
and Exchange Commission, any state securities it in the United States or any other U.S. regulatory authority. Each Purchaser understands
and acknowledges that we may not offer, sell, pledge or otherwise transfer the Securities at any time, except: (i) to the Company or
one of its subsidiaries, (ii) pursuant to a registration statement that has been declared and remains effective under the Securities
Act, or (iii) in a transaction that is exempt from the requirements of the Securities Act, and that the Company must consent to any transfer
of Securities and may require the delivery of such certificates, legal opinions and other information as it may request. Each Purchaser
understands and acknowledges that the Securities will bear a legend to this effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, except as set forth in this Agreement, with respect to
locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities issuable thereunder may only be disposed of in compliance with state and federal securities laws. In connection with any
transfer of the Securities issuable thereunder other than pursuant to an effective registration statement or Rule 144, to the Company
or to an Affiliate of a Purchaser without payment of consideration therefor or in connection with a pledge as contemplated in Section
4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and
reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the
effect that such transfer does not require registration of such transferred Common Warrants or Common Warrant Shares under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities issuable thereunder
in substantially the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to Section 4.19 of this Agreement, the preparation and filing of any
required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of selling stockholders thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Subject to the remainder of this paragraph, legends (including the legend set forth in Section 4.1(b) hereof) on certificates evidencing
the Securities may be removed: (i) following any sale of such Securities pursuant to a registration statement (including the Registration
Statement) covering the resale of such security that is effective and usable under the Securities Act, (ii) following any sale of such
Securities pursuant to Rule 144, (iii) if requested by a Purchaser who is not an affiliate of the Company under Rule 144, if such Securities
have been held for over a year (after giving effect to any &ldquo;tacking&rdquo; of the Purchaser&rsquo;s holding period of the Securities
that may be permissible under Rule 144, such as may be available in the case of cashless exercises) and are eligible for sale under Rule
144, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and
pronouncements issued by the staff of the Commission). Upon the occurrence of any of the events set forth in clauses (i), (ii) or (iii)
in the preceding sentence, the Company shall cause its counsel to issue a legal opinion and an instruction letter to the Transfer Agent
or the Purchaser promptly after request by the Purchaser, if required by the Transfer Agent, to effect the removal of the legend hereunder,
conditioned upon the prior completion and submission by the Purchaser or its broker, as applicable, of customary certificates or representation
letters. The Company agrees that following such time as such legend is no longer required under this Section 4.1(d), the Company will,
no later than the later of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as
defined below) following the delivery by a Purchaser to the Company and the Transfer Agent of a certificate representing Securities,
as the case may be, issued with a restrictive legend together with any customary certificate or representation letter from the Purchaser
or the Purchaser&rsquo;s broker, as applicable (such date when all such conditions are satisfied, the &ldquo;<U>Legend Removal Date</U>&rdquo;),
deliver or cause to be delivered to the Transfer Agent an instruction letter with respect to the removal of legends, if required by the
Transfer Agent. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section 4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the
Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System
as directed by such Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until an instruction letter with respect to legend removal (&ldquo;Instruction Letter&rdquo;), if required by the Transfer
Agent, is delivered to the Transfer Agent, and (ii) if the Company (a) fails to issue and deliver (or cause to be delivered) to the Transfer
Agent by the Legend Removal Date the Instruction Letter, if required by the Transfer Agent and (b) fails to issue and deliver (or cause
to be issued and delivered) to the Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the
Company by such Purchaser that is free from all restrictive and other legends and (c) such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock
that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such
Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common
Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;Buy-In Price&rdquo;) over the
product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal
Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date
of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the date
of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information; Public Information</U>. Until the earliest of the time that (i) no Purchaser owns Securities, (ii) the
Common Warrants have expired, and (iii) the Common Warrant Shares can be resold pursuant to Rule 144 without compliance by the Company
with the current public information requirements of Rule 144, the Company covenants to use its commercially reasonable efforts to maintain
the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act, even if the Company is not then subject to the reporting requirements of the Exchange Act, except in the event that
the Company consummates (a) any transaction or series of related transactions as a result of which any Person (together with its Affiliates)
acquires then outstanding securities of the Company representing more than fifty percent (50%) of the voting control of the Company;
(b) a merger or reorganization of the Company with one or more other entities in which the Company is not the surviving entity; or (c)
a sale of all or substantially all of the assets of the Company (a &ldquo;Change of Control Transaction&rdquo;), where the consummation
of such transaction results in the Company no longer subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction
unless stockholder approval is obtained before the closing of such subsequent transaction, other than with respect to the Securities
and any stockholder approvals related to the Securities, including, for the avoidance of doubt, the Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto to the extent deemed required by the Company, with the Commission within the time required by the Exchange Act. From and after
the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public
information delivered to any of the Purchasers by the Company or any of the Subsidiaries, or any of their respective officers, directors,
employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance
of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of the Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, with respect to the transactions
contemplated hereby shall terminate. The Company and each Purchaser shall consult with each other in issuing any other press releases
with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor
otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,
or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or applicable
Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with
(i) any registration statement contemplated by Section 4.19 of this Agreement and (ii) the filing of final Transaction Documents with
the Commission and (b) to the extent such disclosure is required by applicable law or Trading Market regulations, in which case the Company
shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Stockholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;Acquiring Person&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under
the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, and any additional information disclosed in the filings pursuant to Section
4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents
or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless
prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information
confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such
Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to
the Company, any of the Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the
Company, any of the Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the
basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that
any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such material non-public information on with
the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on
the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall not use such proceeds: (a) for the redemption of any Common Stock or Common Stock Equivalents,
or (b) for the settlement of any outstanding litigation, or (c) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, stockholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, stockholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable and documented attorneys&rsquo; fees and costs of investigation that any such Purchaser Party
may suffer or incur caused by or based upon (a) any material breach of any of the representations or warranties made by the Company in
this Agreement or (b) any action instituted against a Purchaser Party in any capacity, or any of them or their respective Affiliates,
by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated
by the Transaction Documents (except to the extent such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party that is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly
notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (x) the employment thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel to the
applicable Purchaser Party, a material conflict on any material issue between the position of the Company and the position of such Purchaser
Party, in which case the Company shall be responsible for the reasonable and documented fees and expenses of no more than one such separate
counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected
without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent, but only
to the extent, that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred; provided, that if any Purchaser Party is finally judicially determined not to be entitled
to indemnification or payment under this Section 4.8, such Purchaser Party shall promptly reimburse the Company for any payments that
are advanced under this sentence. The indemnity agreements contained herein shall be in addition to any cause of action or similar right
of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. The Company has reserved, or as of the Closing the Company shall have reserved, and the Company shall
continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the
purpose of enabling the Company to issue the Shares pursuant to this Agreement and the Warrant Shares pursuant to any exercise of the
Warrants, except to the extent otherwise provided in the Common Warrants, if such Warrants were to be exercised now.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable best efforts to maintain the listing or quotation
of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply
to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and
Warrant Shares on such Trading Market to the extent required by the rules of such Trading Market; provided, however, that the Purchasers
acknowledge that the Common Stock is currently subject to delisting by the Trading Market; provided, further, that the Company shall
not be obligated to use commercially reasonable efforts to maintain its listing if it consummates a Change of Control Transaction. The
Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such
application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant
Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. For so long as the Company maintains a listing
or quotation of the Common Stock on a Trading Market, the Company agrees to use commercially reasonable efforts to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until ninety (90) days after the Effective Date (the &ldquo;<U>Restriction Period</U>&rdquo;), neither the Company
nor any Subsidiary shall, except as set forth on Schedule 4.11(a), (i) issue, enter into any agreement to issue or announce the issuance
or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or amendment or
supplement thereto, in each case, other than as contemplated pursuant to Section 4.19 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until ninety (90) days after the Effective Date, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock Equivalents (or
a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance
of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security (other than in connection with a stock split or stock dividend or similar
event) or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the
market for the Common Stock, or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity
line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities at a future determined price regardless
of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently cancelled.
Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be
in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to such Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Shares or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in this Agreement, including the schedules hereto. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement
to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby
that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall
be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities
laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities
of the Company to the Company or the Subsidiaries after the issuance of the initial press release as described in Section 4.4. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect
to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant
to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
other than the conditions set forth in this Agreement, regardless of the effect of any such dilution or any claim the Company may have
against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants sets forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information, or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions, and time periods set forth in the Transaction Documents. The Company shall have no obligation to inquire with respect to
or otherwise confirm the authenticity of the signature(s) appearing in any Notice of Exercise, or to confirm the authority of any person
executing such Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Stockholder Approval</U>. In addition, the Company shall hold an annual or special meeting of shareholders on or prior to the date
that is ninety (90) days following the Closing Date for the purpose of obtaining Stockholder Approval, with the recommendation of the
Company&rsquo;s Board of Directors that such proposals are approved, and the Company shall solicit proxies from its stockholders in connection
therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall
vote their proxies in favor of such proposals. If the Company does not obtain Stockholder Approval at the first meeting, the Company
shall call a meeting every ninety (90) days thereafter to seek Stockholder Approval until the earlier of the date on which Stockholder
Approval is obtained or the Common Warrants are no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its commercially reasonable
efforts to seek specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Registration Rights</U>. On or before the twentieth day following the Closing Date (the &ldquo;<U>Filing Date</U>&rdquo;), the Company
will file a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) with the Commission registering for resale the Common
Warrant Shares (the &ldquo;<U>Registrable Securities</U>&rdquo;), and will use commercially reasonable efforts to have such Registration
Statement declared effective by the Commission no later than the sixtieth day following the Closing Date (or, in the event of a review
by the Commission, the ninetieth day following the Closing Date) (the &ldquo;<U>Effectiveness Date</U>&rdquo;) and to keep such registration
statement effective at all times until the earlier of (i) such time as no Purchaser owns any Common Warrants or Common Warrant Shares
issuable upon exercise thereof, (ii) one year following the expiration of the exercise period of the Common Warrants and (iii) such time
as all Purchasers are eligible to resell all Common Warrant Shares pursuant to Rule 144 without compliance by the Company with the current
public information requirement of Rule 144. The Company&rsquo;s obligations hereunder are conditioned upon each Purchaser completing
and furnishing to the Company a customary selling shareholder questionnaire on a date that is not less than five (5) Trading Days prior
to the filing date of the Registration Statement contemplated by this Section 4.19 and to provide the Company such other customary information
it may reasonably request from time to time in order to file and maintain the effectiveness of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If:
(i) the Registration Statement is not filed on or prior to its Filing Date, or (ii) the Company fails to file with the Commission a request
for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act,
within five (5) Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission
that such Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective
date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made
by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice
from the Commission that such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration
Statement registering for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date
of the Registration Statement, or (v) after the effective date of a Registration Statement, such Registration Statement ceases for any
reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Purchasers are
otherwise not permitted to utilize the prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar
days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month period
(any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the date on
which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose
of clause (iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which such ten
(10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in
addition to any other rights the Purchasers may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary
of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company
shall pay to each Purchaser an amount in cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure.
If the Company fails to pay any partial liquidated damages pursuant to this Section 4.19 in full within seven (7) days after the date
payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid
by applicable law) to the Purchaser, accruing daily from the date such partial liquidated damages are due until such amounts, plus all
such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata
basis for any portion of a month prior to the cure of an Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by (i) any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and
without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties,
or (ii) by the Company, by written notice to the Purchasers, if in either case the Closing has not been consummated on or before the
fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to
sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser). The Company shall pay any issuance, stamp or documentary taxes (other than transfer taxes) or charges imposed
by any governmental body, agency or official (other than income taxes) by reason of the issuance of Shares to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given.
The address for such notices and communications shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers that purchased at least 50.1% in interest of the Securities based
on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser
(or at least 50.1% in interest of such group of Purchasers) shall also be required. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right
hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and
adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers
shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section
5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>Third-Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties of the
Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other Person, except as otherwise set forth in Section 4.9 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an action or proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.9, the prevailing party in such action or proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for
a period of three (3) years from the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, by other electronic signing created on an electronic platform (such as DocuSign) or by digital
signing (such as Adobe Sign), such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; or other electronic or digital signature page were
an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights provided, however, that in the case of a rescission of an exercise
of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise
notice concurrently (if such shares were delivered to the applicable Purchaser) with the return to such Purchaser of the aggregate exercise
price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such
Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through Sullivan &amp; Worcester LLP, the legal counsel of the Placement Agent, and Sullivan &amp; Worcester
LLP, as legal counsel of the Placement Agent, does not represent any of the Purchasers and only represents the Placement Agent. The Company
has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because
it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in
this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Currency</U>. Unless otherwise stated, all dollar amounts and references to &ldquo;$&rdquo; in this Agreement refer to the lawful
currency of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22
<U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CYCURION
    Inc.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    L. Kevin Kelly</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
    Kevin Kelly</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1640
Boro Place, Suite 420C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">McLean,
VA 22102</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[&#9679;] </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to (which shall not constitute notice</I>):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO CYCU</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: <U>Armistice Capital Master Fund Ltd.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>:&nbsp;<I><U>/s/ Steven Boyd</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:&nbsp;<U>Steven Boyd</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: <U>CIO of Armistice Capital, LLC, the Investment Manager </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> [&#9679;] </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $6,000,005.20</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock:&nbsp;<U>&ensp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrant Shares: 1,657,460</FONT></TD><TD STYLE="text-align: left; width: 2%"></TD><TD STYLE="text-align: left; width: 49%">Beneficial Ownership Blocker &#9744; 4.99% or &#9746; 9.99%</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: 3,314,920</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Beneficial Ownership Blocker &#9746; 4.99% or &#9744; 9.99%</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (1st) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any
agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be
an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
4, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cycurion,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1640
Boro Place, Suite 420C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">McLean,
Virginia 22102</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mr. L. Kevin Kelly, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Kelly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter (the &ldquo;<B>Agreement</B>&rdquo;) constitutes the agreement between A.G.P./Alliance Global Partners (&ldquo;<B>A.G.P.</B>&rdquo;
or the &ldquo;<B>Placement Agent</B>&rdquo;) and Cycurion, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), that the
Placement Agent shall serve as the exclusive placement agent for the Company, on a reasonable &ldquo;best efforts&rdquo; basis, in connection
with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;) of (i) shares (the &ldquo;<B>Shares</B>&rdquo;) of common stock of the
Company, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;), (ii) warrants (the &ldquo;<B>Common Warrants</B>&rdquo;)
to purchase shares of Common Stock (the &ldquo;<B>Common Warrant Shares</B>&rdquo;) and (iii) pre-funded warrants (the &ldquo;<B>Pre-Funded
Warrants</B>&rdquo; and together with the Shares and Common Warrants, the &ldquo;<B>Securities</B>&rdquo;) to purchase shares of Common
Stock (the &ldquo;<B>Pre-Funded Warrant Shares</B>&rdquo;). The Securities actually placed by the Placement Agent are referred to herein
as the &ldquo;<B>Placement Agent Securities</B>.&rdquo; The terms of the Placement shall be mutually agreed upon by the Company and the
purchasers of the Securities (each, a &ldquo;<B>Purchaser</B>&rdquo; and collectively, the &ldquo;<B>Purchasers</B>&rdquo;), and nothing
herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser, or an obligation
for the Company to issue any Securities or complete the Placement. The Company expressly acknowledges and agrees that the Placement Agent&rsquo;s
obligations hereunder are on a reasonable &ldquo;best efforts&rdquo; basis only and that the execution of this Agreement does not constitute
a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities or any
portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the Company. The Securities
will be sold pursuant to a private placement. The Placement Agent may retain other brokers or dealers to act as sub-agents or selected
dealers on its behalf in connection with the Placement. Certain affiliates of either of the Placement Agent may participate in the Placement
by purchasing some of the Placement Agent Securities. The sale of Placement Agent Securities to any Purchaser will be evidenced by a
securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) between the Company and such Purchaser, in a form reasonably
acceptable to the Company and the Purchaser. Capitalized terms that are not otherwise defined herein have the meanings given to such
terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer
inquiries from the prospective Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION 1</U>. <U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.<BR>
<BR></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Representations of the Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties (together
with any related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection
with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the
date of this Agreement and as of the date of the sale of the Placement Agent Securities (the &ldquo;<B>Closing Date</B>&rdquo;), hereby
made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that there are no affiliations
with any Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) member firm among the Company&rsquo;s officers, directors
or, to the knowledge of the Company, any five percent (5.0%) or greater stockholder of the Company, except as set forth in the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Covenants of the Company</U>. The Company covenants and agrees to continue to retain (i) a firm of Public Company Accounting Oversight
Board independent registered public accountants for a period of at least two (2) years after the Closing Date and (ii) a reputable transfer
agent with respect to the Common Stock for a period of two (2) years after the Closing Date, provided in each case that the Company is
then subject to the reporting requirement of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;).
Furthermore, except as set forth below and on Schedule 4.11(a) to the Purchase Agreement, from the date hereof until ninety (90) days
after the Effective Date (the &ldquo;<B>Restriction Period</B>&rdquo;), without the prior written consent of the Placement Agent, neither
the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any
shares of Common Stock or Common Stock Equivalents, or (ii) file any registration statement or amendment or supplement thereto, other
than filing the registration statement as contemplated by the Purchase Agreement and a registration statement on Form S-8 in connection
with any employee benefit plan; provided, however, such restrictions shall not apply with respect to an Exempt Issuance. In addition,
from the date hereof until ninety (90) days after the Effective Date, the Company shall not effect or enter into an agreement to effect
any issuance of Common Stock or Common Stock Equivalents involving an at-the-market offering or Variable Rate Transaction (as defined
in the Purchase Agreement). No Variable Rate Transaction shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION 2</U>. <U>REPRESENTATIONS OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good standing of
FINRA, (ii) is registered as a broker/dealer under the Exchange Act and the securities laws of each state in which an offer or sale of
Placement Agent Securities is made (unless excepted from the respective state&rsquo;s broker-dealer registration requirements), (iii)
is licensed as a broker/dealer under the laws of the United States of America applicable to the offers and sales of the Placement Agent
Securities by the Placement Agent, (iv) is and will be a corporate body validly existing under the laws of its place of incorporation,
and (v) has full power and authority to enter into and perform its obligations under this Agreement. The Placement Agent will immediately
notify the Company in writing of any change in its status with respect to subsections (i) through (v) above. The Placement Agent covenants
that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and
the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION 3</U>. <U>COMPENSATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company shall pay to the Placement Agent and/or its respective designees (i) in consideration of the services to be provided for
hereunder, a cash fee of 10.0% of the aggregate gross proceeds raised from the sale of the Placement Agent Securities, and (ii) as payment
for fees owed by the Company to the Placement Agent in connection with a prior transaction, a cash fee of $500,000.00 (collectively,
the &ldquo;<B>Cash Fee</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Placement Agent shall be entitled to compensation with respect to any public or private offering or other financing or capital-raising
transaction of any kind (each, a &ldquo;<B>Tail Financing</B>&rdquo;), to the extent such Tail Financing is both (i) provided to the
Company by any Purchaser or any affiliate of a Purchaser and (ii) such Tail Financing is consummated at any time within the twelve (12)
month period following the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Placement Agent reserves the right to reduce any item of compensation or adjust the terms thereof as specified herein in the event
that a determination is made by FINRA to the effect that the Placement Agent&rsquo;s aggregate compensation is in excess of that permitted
by FINRA Rules or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
4</U>. <U>EXPENSES</U>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of
its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses
incident to the issuance, delivery and qualification of the Placement Agent Securities (including all printing and engraving costs);
(ii) all fees and expenses of the registrar and transfer agent of the Shares; (iii) all necessary issue, transfer and other stamp taxes
in connection with the issuance and sale of the Placement Agent Securities; (iv) all fees and expenses of the Company&rsquo;s counsel,
independent public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation,
printing, filing, shipping and distribution of any registration statement (including financial statements, exhibits, schedules, consents
and certificates of experts), and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo;
fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining exemptions from the qualification
or registration of) all or any part of the Placement Agent Securities for offer and sale under the state securities or blue sky laws
or the securities laws of any other country; (vii) the fees and expenses associated with including the Placement Agent Securities on
the Trading Market; and (viii) up to $60,000 for the reasonable, documented, and accountable expenses related to legal fees of counsel
to the Placement Agent specifically incurred in connection with the Placement; provided, that this sentence in no way limits or impairs
the indemnification or contribution provisions contained herein. The Placement Agent reserves the right to reduce any item of compensation
or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect that the Placement
Agent&rsquo;s aggregate compensation is in excess of FINRA Rules or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
5</U>. <U>INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
To the extent permitted by law, with respect to the Placement Agent Securities, the Company will indemnify the Placement Agent and its
affiliates, stockholders, directors, officers, employees, members, counsel and controlling persons (within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act) (each such person, an &ldquo;<B>Indemnified Person</B>&rdquo;) against all losses,
claims, damages, expenses and liabilities, as the same are incurred (including the reasonable and documented fees and expenses of counsel)
(&ldquo;<B>Claims</B>&rdquo;), relating to or arising out of its activities hereunder, its status, title or role as Placement Agent,
pursuant to this Agreement, except to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof)
are found in a final judgment (not subject to appeal) by a court of law to have resulted from the Placement Agent&rsquo;s fraud, willful
misconduct, gross negligence, recklessness, or violation of law or insofar as such Claims arise out of or are based upon an untrue statement
or omission or alleged untrue statement or omission in disclosure in the SEC Reports or the registration statement contemplated by the
Purchase Agreement, preliminary prospectus, or the prospectus furnished to the Company in writing by the Placement Agent expressly for
use therein. Notwithstanding anything set forth herein to the contrary, the Company agrees to indemnify the Placement Agent and its counsel,
Sullivan &amp; Worcester LLP, to the fullest extent set forth in this Section 5, against any and all claims asserted by any person or
entity alleging that the Placement Agent was not permitted or entitled to act as a placement agent herein, or that the Company was not
permitted to hire or retain the Placement Agent herein, including but not limited to any claims arising out of any purported right of
first refusal another person or entity claims to have to act as a placement agent or any similar role with respect to the Company or
its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Promptly after receipt by any Indemnified Person of notice of any claim or the commencement of any action or proceeding with respect
to which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim
or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation
it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and
defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding
and will employ counsel reasonably satisfactory to the Placement Agent and will pay the reasonable fees and expenses of such counsel.
Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ its own counsel separate from counsel for the
Company and from any other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate
under the applicable rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent.
In such event, the reasonable and documented fees and disbursements of no more than one (1) such separate counsel will be paid by the
Company, in addition to fees of local counsel. The Company will have the right to settle the claim or proceeding, provided that the Company
will not settle any such claim, action or proceeding without the prior written consent of the Placement Agent (which will not be unreasonably
withheld or delayed) unless such settlement provides for an unconditional and irrevocable release of the Indemnified Persons from any
and all liability arising out of such claim or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless,
then the Company shall contribute to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or
liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand and
the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the other that
resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable
by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees
and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement
Agent&rsquo;s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by
the Placement Agent under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
These indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement
is completed and shall survive the termination of this Agreement, and shall be in addition to any liability that the Company might otherwise
have to any indemnified party under this Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION 6</U>. <U>ENGAGEMENT TERM</U>. The Placement Agent&rsquo;s engagement hereunder will be until the earlier of (i) December 31, 2025 and (ii)
the Closing Date (such earlier date, the &ldquo;<B>Termination Date</B>&rdquo;). In the event, however, in the course of the Placement
Agent&rsquo;s performance of due diligence it deems it necessary to terminate the engagement, the Placement Agent may do so prior to
the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the Termination Date but will
remain responsible for fees and expenses pursuant to Section 3 and Section 4 hereof and fees and expenses with respect to the Placement
Agent Securities, if sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the
Company&rsquo;s obligation to pay any fees or expenses actually earned pursuant to Section 3 and Section 4 hereof and the provisions
concerning confidentiality, indemnification and contribution, no fiduciary duty and governing law (including the waiver of the right
to trial by jury) contained herein will survive any expiration or termination of this Agreement. If this Agreement is terminated prior
to the completion of the Placement, all fees or expenses due to the Placement Agent shall be paid by the Company to the Placement Agent
on or before the Termination Date (in the event such fees or expenses are earned or owed as of the Termination Date). The Placement Agent
agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes
other than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION 7</U>. <U>PLACEMENT AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with
this engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s
prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
8</U>. <U>NO FIDUCIARY RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person
or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges
and agrees that the Placement Agent are not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement
Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
9</U>. <U>CLOSING</U>. The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder, are
subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained
herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder and in the Purchase Agreement, and
to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement
Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby
with respect to the Placement Agent Securities shall have been completed or resolved in a manner reasonably satisfactory in all material
respects to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Placement Agent shall have received from the Company&rsquo;s outside legal counsel such counsel&rsquo;s written opinion with respect
to the Placement Agent Securities, addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably
satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
[Reserved]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
The Placement Agent shall have a received customary certificate of the Company&rsquo;s Chief Executive Officer, as to the accuracy of
the representations and warranties contains in the Purchase Agreement, and a certificate of the Company&rsquo;s secretary certifying
(i) that each of the Company&rsquo;s charter documents are true and complete, have not been modified and are in full force and effect;
(ii) that the resolutions of the Company&rsquo;s Board of Directors (or any authorized committee thereof) relating to the Placement are
in full force and effect and have not been modified; and (iii) as to the incumbency of the officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
As of the Closing Date, the Common Stock, the Common Warrant Shares and the Pre-Funded Warrant Shares shall be listed and admitted and
authorized for trading on the Trading Market or other applicable U.S. national exchange and satisfactory evidence of such action shall
have been provided to the Placement Agent. The Company shall have taken no action designed to terminate, or likely to have the effect
of terminating, the registration of the Shares under the Exchange Act or delisting or suspending from trading the Shares from the Trading
Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that the Commission or the
Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing except as otherwise
publicly disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially and
adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order
or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which
would prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially and adversely
affect the business or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
The Company shall have entered into a Purchase Agreement with each of the several Purchasers of the Placement Agent Securities and such
agreements shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon
between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all
filing fees required in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
The Placement Agent shall have received an executed lock-up agreement from each of the Company&rsquo;s executive officers and directors
prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 9 shall not have been fulfilled when and as required by this Agreement, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such
cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
10</U>. <U>GOVERNING LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable
to agreements made and to be performed entirely in such State, without regard to its conflict of laws principles. This Agreement may
not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure
to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect
to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under
this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by
execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally,
the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to
such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
11</U>. <U>ENTIRE AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and
supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by the Placement Agent and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities for three years after
the Closing Date. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION 12</U>. <U>NOTICES</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent
to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b)
the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages
attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business
day following the date of mailing, if sent by an internationally recognized air courier service, or (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
13</U>. <U>PRESS ANNOUNCEMENTS</U>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on
its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[signature
page follows]</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.G.P./ALLIANCE
    GLOBAL PARTNERS</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 43%"><P STYLE="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                            Thomas J. Higgins</I></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    J. Higgins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Address for notice:</FONT></TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">590 Madison Avenue, 28th Floor</FONT></TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">New York, New York 10022</FONT></TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Attn: Thomas J. Higgins</FONT></TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Email: [&#9679;] </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to as of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>cycurion, Inc.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ L. Kevin
  Kelly</I></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L. Kevin Kelly</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cycurion,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1640
Boro Place, Suite 420C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">McLean,
Virginia 22102</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mr. L. Kevin Kelly, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
[&#9679;] </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to Placement Agency Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cycurion,
Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MCLEAN,
Va., Dec. 04, 2025 (GLOBE NEWSWIRE) &mdash; Cycurion, Inc. (&ldquo;Cycurion&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ: CYCU), a publicly
traded leader in technology and staffing solutions for the public sector, today announced that it has entered into a securities purchase
agreement with a single institutional investor for the purchase and sale of 1,657,460 shares of common stock (or common stock equivalents
in lieu thereof) and warrants to purchase up to 3,314,920 shares of common stock at an effective combined price of $3.62 per share and
common warrant for aggregate gross proceeds of approximately $6 million, before deducting placement agent fees and other offering expenses.
The warrants will have an exercise price of $3.62 per share, will be exercisable immediately following receipt of shareholder approval
and will expire five years from the initial exercise date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the offering is expected to occur on or about December 5, 2025, subject to the satisfaction of customary closing conditions.
The Company expects to use the net proceeds from the offering for working capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.G.P./Alliance
Global Partners is acting as the sole placement agent in connection with the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin
Kelly, Chairman and Chief Executive Officer of Cycurion, commented:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We&rsquo;re
thrilled to enter into this $6 million at-the-market placement with a single institutional investor. This capital accelerates our inorganic
growth strategy, fuels continued execution on our backlog and strengthens our push to lead in AI-powered cybersecurity and mission-critical
government IT solutions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section
4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and/or Regulation D promulgated thereunder, and
applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or
applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective
registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state
securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investor, the Company has agreed to
file a registration statement with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) covering the resale of the shares
of common stock and shares of common stock underlying common warrants sold in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cycurion, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering
secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity,
Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries,
Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate
clients committed to securing the digital future. More info: www.cycurion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act
of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact
may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the anticipated closing
of the offering; the Company&rsquo;s anticipated use of proceeds from the offering; the acceleration of the Company&rsquo;s inorganic
growth strategy; the continued execution on the Company&rsquo;s backlog; and other statements that are not historical facts, including
statements which may be accompanied by words such as &ldquo;continue,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo;
&ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;expected,&rdquo; &ldquo;plans,&rdquo; &ldquo;intend,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo; and similar expressions are intended to
identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause
actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside
the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes
of the Company&rsquo;s investigations, any potential legal proceedings, or the future performance of the Company&rsquo;s stock. Additional
factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be
found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion
with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions,
and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any
forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law.
Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion&rsquo;s plans
and expectations as of any subsequent date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cycurion
Investor Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(888)
341-6680</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors@cycurion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cycurion
Media Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(888)
341-6680</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">media@cycurion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>ex99-2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cycurion,
Inc. Announces Closing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MCLEAN,
Va., Dec. 05, 2025 (GLOBE NEWSWIRE) &mdash; Cycurion, Inc. (&ldquo;Cycurion&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ: CYCU), a publicly
traded leader in technology and staffing solutions for the public sector, today announced the closing of its previously announced private
placement with a single institutional investor for the purchase and sale of 1,657,460 shares of common stock (or common stock equivalents
in lieu thereof) and warrants to purchase up to 3,314,920 shares of common stock at an effective combined price of $3.62 per share and
common warrant for aggregate gross proceeds of approximately $6 million, before deducting placement agent fees and other offering expenses.
The warrants have an exercise price of $3.62 per share, will be exercisable immediately following receipt of shareholder approval and
expire five years from the initial exercise date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects to use the net proceeds from the offering for working capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.G.P./Alliance
Global Partners acted as the sole placement agent in connection with the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seward
&amp; Kissel LLP served as legal counsel to the Company and Sullivan &amp; Worcester LLP served as legal counsel to A.G.P./Alliance
Global Partners in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section
4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and/or Regulation D promulgated thereunder, and
applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or
applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective
registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state
securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investor, the Company has agreed to
file a registration statement with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) covering the resale of the shares
of common stock and shares of common stock underlying common warrants sold in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such state or other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cycurion, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering
secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity,
Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries,
Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate
clients committed to securing the digital future. More info: www.cycurion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act
of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain statements in this press release that are not historical facts
are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained
in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but
are not limited to, statements regarding the Company&rsquo;s anticipated use of proceeds from the offering, the acceleration of the Company&rsquo;s
inorganic growth strategy, and other statements that are not historical facts, including statements which may be accompanied by words
such as &ldquo;continue,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo;
&ldquo;expected,&rdquo; &ldquo;plans,&rdquo; &ldquo;intend,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;predict,&rdquo; &ldquo;potential,&rdquo; and similar expressions are intended to identify such forward-looking statements. All
forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those
expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult
to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company&rsquo;s investigations,
any potential legal proceedings, or the future performance of the Company&rsquo;s stock. Additional factors that could cause actual results
to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on
Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the SEC. Cycurion anticipates that subsequent
events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically
disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events,
or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be
relied upon as representing Cycurion&rsquo;s plans and expectations as of any subsequent date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cycurion
Investor Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(888)
341-6680</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors@cycurion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cycurion
Media Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(888)
341-6680</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">media@cycurion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cycu-20251204.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaSLWbP9z5Z8GekhvWB6bVmqbykrWNPB4Cxd9HUWwRAP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:CYCU="http://cycurion.com/20251204" elementFormDefault="qualified" targetNamespace="http://cycurion.com/20251204">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cycurion.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cycu-20251204_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycu-20251204_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cycu-20251204_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="CYCU_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" name="RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cycu-20251204_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cycu-20251204.xsd#Cover" roleURI="http://cycurion.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cycurion.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cycu-20251204.xsd#CYCU_CommonStockParValue0.0001PerShareMember" xlink:label="loc_CYCUCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCUCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cycu-20251204.xsd#CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="loc_CYCURedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCURedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cycu-20251204_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cycu-20251204.xsd#CYCU_CommonStockParValue0.0001PerShareMember" xlink:label="CYCU_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CYCU_CommonStockParValue0.0001PerShareMember" xlink:to="CYCU_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CYCU_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="cycu-20251204.xsd#CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:to="CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember_lbl" xml:lang="en-US">Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cycu-20251204_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cycu-20251204.xsd#Cover" roleURI="http://cycurion.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cycurion.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cycu-20251204.xsd#CYCU_CommonStockParValue0.0001PerShareMember" xlink:label="loc_CYCUCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCUCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cycu-20251204.xsd#CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:label="loc_CYCURedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_CYCURedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001493152-25-026365-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-026365-xbrl.zip
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MF2TX@71>@-)AKO$J5R:O@>*H!SJG:93NY.R0ZXWA12RSQ!8;D+F""7V_%RP
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M8K?.E$'H$4FP.X"?7'E0_$ R!MU07Z"9O*"H$_?03/I",_$:FLEKH+E_9IY
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M]/WRZJ8K\4ML+C:)O^8X(6++_P%02P,$%     @ V8&%6_G=EH]D"   MF,
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M-:+0GBP)YV]3;5W6P6'GR!!*NPDK@"LUHM"^75(UM^/=;TH^FT6^AS9$W5,
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MC%>;DKD472I+,<\INL1GLED5.9^PY3POQ3Z#-^A#XPG;9-\1I?HDRXMURR.
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M'ZN@'K *ZOE8!34>W(>Z59K!-CE4/D'J?\TP[+2J5X):IW8IK73TC$'GKS$
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M15PDE=^Y&$^LFHSPOVV\W&6%^VU'Z*M9Y^8;88V?TY0&Y&6_%@&^,\#SL3/
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MQ&YU\-/P&;0:%QS+W'[R))GA!C_?:+@+^C.R)[_SJA(XQ[4OL^U+6$=2HF#
M3,";< '&*\Y(OI$W'D ;3H=#G=]624WZ\[7E.(NM?S&HB<6FZ6@>G!!?E37/
M#G^0OB0<O=RBJ<[MV$Y7>,LG13-058D"OF4/MVX>"A-9IP'_,RX'YUDVWJ=
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MEE6#@9V4[2TX1EB=YT?L5DV'$:CH@QL@"/\5K_W*Q7N693Y?(^( GXLRMBK
M:K_?*G$IZ9"J^>15(ABL?*S9?TJT+UOF-+3P^Q7\1?>L]W,(_H<O^(ON4>\W
MG?RA@C]]6O] X1[10O7#]]VRO:A3M6=+].$@=-5&\/.9JSZR2M5.%7?839>V
M9)'7=(06ZP;C+Z!8GP35H++^5"A*R<1\Y5(<K/]"Y5NICSG8\B[(+7MF6_SB
M8:47/;S.FTX^3>GM?79=\E>$V 0[;[=X.MEY"4EULI)=70.-#U1]ZL.<L\Y^
MN!VE0\\A.+845NI&(YRZZQ=L \K49CB6X\?!2'O.)%<&JI$!Z;YXP999^R?O
MJTQC#I)RG7-'-S6A9G29S)X9)5V2=5Z=C 2>67.?J4TG K8/9[0)1V"3SUXR
M\/-^N)V@^VPW%#2QUQ[84G@>36@(\\5KCZ$Z:D?W7.2A@N^]UYAS^\*=P3H&
M#+[EJIO]]B"]V ,E[)O_:!ET8)]MUZ8X,K,D7 )[%EMLO##0E%6F435:[I8%
M&Q>V)&=SU5]6$E=>P::"9S^=D$5NZ['H\J5Y*&;?4)_B1X)/?.)N:F R'"/5
M.OJFHBLW'(+H&XM5\'_;P2#JP2=AU&PH18T10CA$DO!W/-D?R^J6*!PZ6X E
M1>TMJGA<"M",5QK3L0N$/0;!#GA"L^LCRX&$(CM<J$'FO/";BV0WEF$GIM[#
MC21.._42'J_435;Q(T/UJPNRU85]*C0O9_8*.&7"=8NB&,IRGCPG4N4Z.OEB
MEAUY_+I-)[:W%15V;4Q28T$S."XV8SB=Z+#%S!H\S75%""QP8?,JLS5.[F)+
MPO0?N-&2>Q;H!@X.YVR)-1GU +;!C+*-%7RR(II1^Q<BQ;13Y'N1FL5+;9@4
MP?CU]9 R'H$C?N#/(Q\GMXK0F3?^E.R*L#+)S!3=C2*>T7DXK'XNO845$DRA
M*8A;'"OJ?URH-=PK:^.%A3.LKB 3FU2SY\<Q=O0#F#_5?08,Q"1MN_)$G\KL
M7/$1OBJ%?B;!JA@@@.-5XNH62%1X8:TR0L+D-2PQ]]2V9:"^8@-V'C4\IEYC
MNI*6>5,8RCZ/:N^ )T3=. C"8E/T%TX>O [$G#<&_TFT?&VU$IWN'1D>61 (
MX\ZK_:.E)_#'E9Q0?UX'/!^*Z.WH&,+6J0_Q87(03AI3T-$Y\8H9GUT[KC<%
M+G,13H7Z"&T-JWBHKDJJ485*UR;T&*)P'%TP7F%@R52G [A-DEX=DL#]U!14
M*8^BG$[1!/-,>#^55&!"V]AH1,7WIZ<?0I8N7"=FCDYHBY$0&S01%WYG<.W8
MBX!U/<[V!JN$ GX3*6SQB4$IN.$1-5NG+Q=0(!I<*2;ET>@/K<L$I"B0.K!;
M_4/PY:AMG)4/4K&HJI:?JB\BG#W;]T@=4%# %G$<VV6)T2]VY*NJR560G]QB
M5\B7DVBJ,Q(0H$AGES)SMVZ6N$G[PK)A;@).1"<-K&)1W3;N$;(EI'Q!!DNJ
MMY>@M%/@%KWHE]&O'1FZ)8*N"OC\TLX_)E/@B2%("^)T%3AXU.0'/*'9+ZS)
M'9#T%1F)S4O0")Y@[^R&]_ZMD.&(&_W:@!54K93:OPA;,(A&Q!!9T]Y]'UB;
MC95 1\U''2UO^;BTX;2%/ZGW.<'\$75\XWI.$+@_MD3RI$LK9&YQDV3M@E^Y
M3C)61? S0_S_$%Y7 (3E,+\,E@@&X/!KND(LW3V"M]6^S%"K@0X60@,-</?1
MF=GI$=/\1ZMD@W>>E'FF:8VI"AQ^B8!E]Q:$!.&PX):!C:L9 ,IJPK%.J,N
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M1[K-]3Y972=4[MFN7,<S6"G6*B'$&8X][$-?(^RNSEG=QV,;L@/P6J#^ LS
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ML!<F27S^C WR;8O;M52C?U.E-L(WG2S!S;?]/VV@U4V#ASB>]P.>T.Q7:=,
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MZR)&%F"KO_>IM/4"/Y)NO4]6XMDV*_&068EGVZS$=@L_E"[$4>&Y?3<PL4E
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MP"C;#=0ZZH%1?JH2C0]P+],H1&HIL7XAEV,:'9.=MFYI8-QTE[\("]7<8;?
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MU1SENBL[G+'S[-V3NI7["[K6/&^(%+"7[LQ[F92,-9)U3D9&<Y4@:L&7CQ*
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M WO)?L>0]36+;TRW4L )GOEFR'EC=Q[7J5=*[^!95AO=H;0FA_W\ :ZWB+D
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M6[,L#0NM @;8?@3SWDFR/NYF^]-=MTH('I)Y#_*R3J8!9W<$J@%L<"6\I(&
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M#'_&<U5BT7L/"]&=G(#AP!-#*>45DNVNXZC<5^Y1)KH9*>":CYD63"=B<N[
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M5.WEP00_PX$7KAU%BBT-K100J>2_XF>_J%C2:8?" EXO:M?#R))Y65 8&[1
M842L/F.]S%)2/8 \:3S/_2Q>79UIMH&8^'@LA'[H/IWD)7+/7GJVT*77XM65
MI!/^^M\NX_#QG\3W4%/X_/FWR2D\;F>^'!/7U1;IMA'I]N<40G_\:W';_&WS
M'VOS/WMU^OH7.,T_7/QX_-W_!U!+ P04    " #9@85;FO&>4ZTJ   ,]@
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M[D6,Y",$M(6]X:*1?1AX3$Y-1EDD#D$;Y#-P'C- 5%QD3@,G%W2X*;&B292
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M(9@'^!)YG20420+(CT76F&V(2A_%!W!L/[QG9_>=4>W833N*IE,38L &XPO
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MO'FZE/^K*W/+NL-(S6]?3R/84NMZ2T6#5> \1 XE+@]T$++ZSED-52&",9*
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MU+L9Y[PA1-V(2"]D-PZ:N@8\$)@L$2W$^5FKII@N=.)*!3"R8E@'K))=K/X
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M:>J_^ SF"G0BT;5WPIJ,%U60Y1725\1$Z@ 7 ]:EG!3).*8=P^EK56=:Y+/
MEJ*!$J(P^V O3L,K.#6P5,4\+WA<CR0X3'-8)(^2Q1P']MEI4.HS..$S6.(9
M' 3S4)VDOVQO;6]O/POFN!/X=,-XCDJFE[07EO8)"".\I+,863PN!UX,7 [G
M96KM^6[8KP.;%9[4ZS0O\#P#W7D6"UW>10IH '=+X4'80UCW^(\%<F4YF/I8
M'.-;8:'+((JG2<;[#K?O%.: 2_V\-^[C%=QZ5%SM03O92%LS6]3M/*,-PEW;
MPSUDAB*;MO-&L4#X?22<:H'W&R\AWM0<K^H5G@5U I@5R=&Y""]C.C*S.,R2
M[+PTW F/"K+A +ERF  E0-*B@/%A-IKI#\^+.,9+X%^C^A/.#2;V%@5:88";
M_*/1&>#(PKD_)\KD_BNN:LRH HB%/0BKO%@R1ZKR;WN0-X>V[= ^QP.*&[X5
M\#>*)>G/'^Q,'Z$:V M!^;(V"46/I:!M!?87E2VVR, H03V;@WA#>S4*QDM7
M1LW")4JH61B!) *><G61IS$I9QF*Y<K1@KH=^*(B\GU]J%'G(:[ 3XYC8%O,
MS'PM!FF*XA042.04N<-68$9A$"W2)2I'DP7.8!I.2E#M4J!FDL^7^/+CO;<!
M_1D4 %#Z9)[QTUD(6E8/'I _AE453BZ0V_756AWFE8AV37G"BB4JV#"!# 9F
MMHQ:1:DO#$6W@J&Z,=V.QV'K+W;UBX\)[ ./%(=%FL ZHB:9](/J*@]ZS_O!
M61%&P/1AC9:LX/82_!9^D"V(*\/SSC.@5(&B4L+?0=> QTXK^%581'"R*E";
M20X<PR'+(]*6VI2.J ]4X+Q$&/5A*=(TOTJ$Y:-LP+&-1@WDX>Z681*QBL7J
M>[?#8DPVE[X)ST'@G.,;7#6(=%-W;JYV%I3S>(+F1Z0V*)S/TV02CM/&780#
M<)7@B2-C"8F! <!2NH"5_EM1XB[ BEW$H+I%17B5X3D-@P]PC&$$6+D*AAR'
M&2IV:5R6;#+ S^DO>NKS(I_$T0+&<<ASUG/"BSF.80V[G>2V,]F"S^#!3T]S
MN,YP;]*FV6I5LP!=$Z8-^Y#EA7R,%VD61_!').A\$>*RQG!_\&J0"A)4RSF]
M4'^)UPHTE+!(_H]N*ET8?%'34IMAD=CJ"HYVB6</3PS\!@_ZN=)LY(*#]04[
M4RP'?%3YP B]J!E9[\2?S"^6)7J:4KSC11'7E6V/<2@+2[\:&*)FC*" P3#"
M ;0G2,Z9/$2[H2T';36JX?!UXSC.ZD8;<<RKBV1RP99C;7HK)]#MJ!E,Z;QF
MDSA-F5=>*8X!&EO0>^$Q")D-7\Y,$8!\K.W,)*6ZF;S&UO)M=3O'P/R1H:OY
MR0@6P;!8B[1" E!6R-*6S++!7"2:A:HJ1S] Z]5N7G):+;#>E!(<3Z=HW,'/
MX2(!&Q-VE"\J?=AN.0()PQ4LA^PVO3'6+;UN'#X-<,8SX0*X=[#QL"5S;UW9
MTI0#HDZ9.@-\8$!V9:CCHY\E+Z(2^:IAQS>@1;U6<6XF1.T84^ .J5@VR6 R
MJG$6* $U"P"&:ATF.9QH'_>>.4<3!R0'T;S28V?TACJS$+D;G^?PMP&O&DQE
MKHQZ/7BO[-MGN=LQ)YGU#1"$*%#RX)>7V]M!N#7;"GJH<OV6%Y^"W:1BA:8?
MB!>I47T9R"T2'<D,83N&C HD&M)45!7K^->MK8%K/.'')5(K8PP"NOQ@*^*'
M]M@#APLIT6C\'M;RPAIU.W#$?\05F/_)%5!'IUF_TV*G1A0ZCUBCVR-/&7(S
M.''S'%F$Y9!YO8_J%(C1RP0]EVC2LDJU_P:NRI)T%EG%5M6A)S+L(LR41$67
M*'.BFLSNDPQ6+DOD ;1F*Z@G*\F[I;1MY+N,897@)>%D$L\KY-<^HX1%G'S*
M\JLTCLY9):;]1L&';E3X;1&'I3DMM!@E^RWE3< TX#?A_&+@Z6):U6_BNMXI
M\=Q@S#?HP'H/AI>@+!.?DUWC(2QAR.?_')8HXUMPE? Y$%4I%+UFEB_0#U:1
M-T$.&NCO_*Y\^NUS%QZA<^MK3\F?S+\]?1J\3>(T>AD<A^?Q*_CA'XL8SCW\
M('CZ5 7*]O9_5</S7)Z.\ZK*9R^#GS&H.P9!%A?ZLYT4[DCP#"99YFD2P:@F
M\&D'.OU J(P@;YO W0CG)5"B_N1$.ILF9\*>#<%,=[W3>$J_T!% )XBJ=E[%
MT50,[?4/L!(-BS*&2__I*9O%+^&"XTK*0L'(M$HPV+&[AG0>S%C'[MNMG?D!
MMX9WXZ&?OT=XI7ICSZ-#<HR=.6>.I+,,S:1)LL2?4>IP8 ?$_HQT_?J/[+"*
MP^S!_+I"PZB(GTXY=N@[8%QM:J6K9X :;TG<H$J7:($&8<0Q-G@<OP,9K\)(
MELPF[?I/$-^OF[VB+LW#)%+:O0AM41^/XZ)D35;,"?PPUFJDM\".<NX8IRH4
MJ1:EB*M%06M5Q+B2))#1&,Q9B1;1/##J-RPYD5G?[&Z'YZXLSV4P28K)8E:*
M>E%(($\K#E>@2)1Y3(ICDDW21216&9E-EZA#-02F<"9D7'EVK-ILMLQ];QTO
M21&C48*C+#*:A;=MM;U:&1^3'1Y<&\#SPQC^!;(<;(^*83Q&'CAA'KBK]',[
M!H&'S'-2AVE)5UN?TW9W-=TO4DO'2PJ=B5-"SDW-(I S W:![3=Q;KUWX\5Z
M0)Y[$]]! *^O$C)EQFC(L]D1)6#SX!7Z5V_X=*<?]/[9_Q_XO-OI#?MH>L*A
M?_FHMOPQGN(AG.*_DP=<>X=>LA<?MOW7C\-C9?;8'I%D-HNC!)AIND0Y,(DC
MW[=^O7\[$3FBO^IV;,\>.F% N;XP<1,T/(T+ ZRZ<B%N1\=;'1K7/^4[8/PE
M7'*L&=Z+0B-TW3L%12N<P;J=FXZ&@_6=T>QW.WI'/H])XL"#<I-!;B[2L$ ?
M/_WD(H=Q5-)]+RS1+:1C'"<+6,B?M[=!^<)7G-!OB8S#]Z=H=,\6Z3D9JDI4
M@:T:H\*2!J6)K:?A54E.$UI]B]B!B<_L@$ \-@H;.W5-JHB<")A<-DGF\'KU
MEO=A\2FN\#05,2H,S"=VTCQ')G,>'&P=;P4](_[T-TXF3*B=P9RY-+78F8I\
M=#LU)]4MCYOC1]:'+%J07_8F^X.;W>W8NXUGQG%**X^W!,3HYU9V$RRX5G;$
MW^\\:5QSDS1G'TDS8:!A^)39.]N_\6U!DI*&RW_C:PTR:.K\8L6BNU>%,^!:
M'[X]+^AV_.G=>#UK&^W?E<<E!!ZC7-LAN=:2KL:ZN83%B5N^PB.U21I9HPW\
MI][ 5A659/I5OD@CU&^3$I@ <B5*K=7VG!_U WX<3C ,1;8H16A,&F[M869@
M)&TD3@0GQE/+41\WXQ6A<0PT>.\W=MV:3VD?%%$_GE#PZ6(]C&1!P\YR5(+"
MH_B;II"):*'U$Z@$\@N06+U?^EKMLG(BAY.J.79&]ET5?HJ5L 9AEF#".I [
M@6?""?R9,MI++[""&0 HT+1)ZD92):H'&C.G_N(0[ HJR2>F<R!8P85KTY V
MLLG$NR_RC9:=@#WC.YB8@0VT)RZB:*FH]1,,V%;D.(NU'W*:%*6.99HHWB3%
M,*\P8](-L1()SG$@FJ!M.E#H$C[,@C0A 0RCHV^!HVNA9T@P/>,DLKW'[@MU
MVA69"G"S_EC$I3AH)1\KQFM2678J3A6$BV?7BNWBI)XX([52WFKN],:4O5"S
M"JEJX9>7+SBNW^TTAK7A3OWX<OMY>^"[#P;;F%;YZ&SWOW>0(/S#/^M6KKV:
MK-4W[0RN)/$V4MVO63Z<E#>LXT, VB:-)T!1U[R40 /P&B&[80@TL*9\&DJ]
M]<[K0T[2S,R6P%?(U8Z3[%-P!":XVND>Q1PH%1,T_[PX#S/)%0N0BO \SB84
M6Y_$XM_(J>)GNL@FE8IN\RCX+1/5YU6>Y65%3C;@T^;\FJ(0O_BBS#6]Y''O
M17T2$Y@_Q($&3 @H!Q* 3@ID*C@)KCHA-:3YS90G:5]ERC&(XGE, A2WK B!
M]V/A4 J\FV7<>9YCHBJ*)K[]P$!,7CP--PM_SPL\C F^$,6-X0Z6V**]L%.<
M< _9[0_G1*<=H-[F1FYDKBB!\"?Q9Z 8EH!"''Q#M6?3CI:H!+"'R[<?MMBY
M1;3]^2NXCW237N( HCF\"G[%,PU??U_!^'IMME?E?(=[9&V*VHY7P=ER#D\,
MBW"<3%X%A^$LYBT[S'$CGCO1>?4K_*96@?O=9 YLKGV#MGFF7)*@Z=3T35$U
MEZZ:Y:E@H"&@JYSE.W]EAX5O^0JC3W"2P9P+"%!2H<KH)GQ-8&5@O@6K6!LA
M<N^G"=55ZQ1U._=BMGBZ/Y5B7&>V1"%,/;C,TP6F%\98R82V @@&Y$^K#9H;
MJ^'?JQ6S<EDE"^9+UO5.S)MNI\F^">[#O,$3Z]@WP;V9-W1YC'T3W)=Y P:O
M9=\$]V?><*Q9V3?!.IDW#QO)Z5M%*B).!'H?PP'*Q,OJ) ,]JNG>_PX^N]L)
M)5NT?;IBHAYG^H !)3^]RZ\XDFJ7NH/>E#&9-$#.\J323EWOV^W@2_=B<J\C
MZ,!9 =/7HU071;XXOR >+0\A'\<R7*S_#+$Z.-A%_35*@ F62Q ],SO98N_C
M<-<%I)G:+$5I!L"..(B!J1T<+R.Q*2\D7I40ST;\1TIFH&!^)@FIF%;&$0C)
ME*7J":J#F2.?KBJ5*T0!N\RH0>ZZ8<QAP/FH98@Y<M/&\ ?P14ET0[&RTP]\
M4!HOQ!%<)HVQ&ZKTKA2:!;Q556SJTJQE,YT#.]XB*:NRI+I,EV67>DX]E85^
M=HL"%8IB59CC5A4W%;MXB!J-R2\B>L(H*G#6IG[733%66]U<C:RS.E!E5HY\
MJ?UFV=A>_&U@A]KKY)MIEZRDIKH\>FM]>UK+K'P!+"7I-ZU)9]'?6I(.]^;/
MSS+H:=5T)<:/6]?E%N03EU(C:QVX:46;LD,CK.MC!96XF2 FQ:;H#>8BV=:P
M)LSI+N343J6RL^TF^W60RC:Q;FJ]'AEL_D)^@SPE=_.*KKN4#75Y"+;.E7E?
MJ3 OL.ORKMKP$8"Q?3E PC6'T3)T_85JR+?<"O9=40":<5KZ2?JFNE,=:U69
MT!"4MO+@5[ 3MW3=/=QNA2F?TWFX],;&*F78!\KJ29,_%@D#_T3A# R<4N,4
MH?$&XB<+TVK)3#4.X03^Y=E@>WO;DOBZB-ZO2-7I'<8:7A5-NW7>'!A6?WFV
M32:4[4"C#$%<?S'0_O+<>8;S5Z4L,9E6%W7^6-\==YG[9C7JO^7<EQ6_EK3%
M>@$J)TU81<V%VC'X;@*:7.FN:V/F 4Q8E8ZC5J*0,,AVK2%"G:EOA^<>&E2@
M<G]KB@V^X>WP] RS9\^+<(:&:HK(4&$9>% !2 @&GSQ33^C'7=T*AH*.Q4@1
M XNX]IM:=Y$B4:5ZOC3/L^,22Z80#:=$-Q2:T"V\8J#.A:^+  ,A!Z?G,?)9
M=-WS4.***0P#<[Q)TK0R&8,"\H@LAL=G C780/AKG2?48 'M>ZER%N);'5>$
M2UMJ#)VJ7:H++G]C)1(ONE6F3KE\!G#$S\\32,\)E_I7)A/D!AI"LS"#^V0F
MWNW$J#YD$R5Q!9#*5=H1WD75F./'B\R8?!Y31 08T;(\("N%U6"-+DM*S$\[
MRN2*EI3QB(<!;125QF@5_CVBT_D(KYO<MQ.4A25")00G=+(4'AH5Q38@L(1V
M8NM*W(ND2:.#DVK<%$I@=CLD,>D>B$/B>@6OM:# @&^Y.EZ3]C!@]ZD9"2T%
M&S:2KAO7JY'2X.D,&R?H?5!_BPR/%YMDCK5,YGBQ2>9X+/?[VPBL2Y97*$WB
MK&2_+BHQ.XOETWV"'GP+ @9A!(%9X\O2I6+U-W"FPQL4SH*".1!EA]4M@^>C
MBOI97-Q&R@5_0LBUE(H8?".R?5K$7SC.+V-'3GK"VP4572DF)3!LC'+EB#6"
MDUQ/@B$!DA>]R.,B_^2IISV<4L:Y,1)BI>4()RHNK'W@_4!<SV[AI;P5K^4T
M*6:6SUSCL0T(-[,!K-]V(:&O&<Y1.55#4XP7'?VN3[H9"JI6Y1YF;->C\X==
M<.1"$?/!<>"$EEW.Y]>%CM8ZB>M[PF@'^I_$X]1P>A@MB@XE^9<1P1/I['9Z
MG_M-2\FH@AY(NU43:I8:X>9942S5^_LZ-N#[WG(KY(3X*G%4!KUEGV^.0%K9
M=?PS1$&<ITL<$GWLK@.RJ>;*7IVKT#IYK3Y"1Y<5AS"Y1C4&:\4E-@+/B^[1
M2F?U&$!*](W$: RA5$< +R2ZD!B' PL(4P0.R:P*:52UH^+WQ_I F4D^M\N(
M%6N1(!=Z<BB"Q>0T Y21)PB6X!+.+_RU=?%PQR2X;Y])QK A.),\RW$=>QK)
M@?S-[@GV??:B',<17=EV'ZTAJ_EZ,J";%-090UXJGRY"%]JQ8BZ/+NDT$7\W
ML1VG484QPO5N6$!N6\%;=#Y^#N$=VF;I=H1F \G9PDZ 1O+#-5\D1-YYQ@Y>
ME @YP4$JB55'9D1PY7@VK^+(VA>SA:4VP$RT@-@5#W;3DTA$;2-1 RG3YT0T
M8B]RJAK1%8"GHIZ"@JC.FWRPV=!AH>SE;H "DNB(>YT+C$=G L&(N33H75'^
M#^8>(/=@"#NIQ=QRM:8R%UEN E<B9FP\/6XP3APML9$*>3U^YNV:R]&DUCS-
MRY* .6W07IXO=50)0I\-:RN3A'5LZQ]XOY+8U4#@D-M0A!A72L,KP7#!7:"D
M(>'AC &:+RJKG0NV)HGB"=8#(M$<C)V@?Q<ANTG7@/7Z@5[X.V5C44@=;MFT
MS4UK>W@IL4GI8G)+HV9=K*%2UF)J%E^WU1CRL5&UK 9!?#2*[J/3W$5Q![/O
M;<&:%C!*U4JI"$XG13)G)1P>F9I'O(."N9/XJ('BIX3JUN<U6Q+A@0>-;VM;
M739%3T3Y5^]EI=#5C&N:'XLK*W7#13K23%BK@J:8N\TC35(L%9V>=&_,EXT7
MFD%;B2O$<]H60FL1F!F!7)DT1]+!0?M@OJ5QEIPW*:7,2M+P8M.,U=$/BGQ!
M?G)U-3,X30(KY="RN:9K/*%+<0COPDZ=XX-GX6<)7X\D,=3DG>GCYRI8]<P@
M=0FQ.8:60Q,:PA/<*M1/UY6[9"B[N0H_:[L0Y1H%'0CGD.AJD/FUZ^%'7@2\
M7JZRGJE.@17@].;4UX%!BKF&Z:Q.LQ*[D+\MZ/_8S4V#98/<FU"NOV./OO(2
M2U1&B4HXN<BO$,;0?,P8R1Z4(?"8AF@Y)P4:XD,A#E>>=/.V^0S:LHKTBJ ;
M U?/8B=# G^FR#(HX;.!-!=9T2MD1_4* 0/?;6GBFNP^"#RNJ&@2C+YB6M?A
M<SB8PD[0:3DA[,X,_IV"9I2(XP8TN=D8%)$8-3"J["$[Q#ZHUOFLU#2(FB;4
M1JN/@:MFDK;*5K9K\=4S D")-PE+&+NTXW=V(Q:!(+)L-Z]S@0+C;LHMG1-^
M8.H[LZ@X5NMH5.  9^-I%"X1@3.?Q&4I>&,MC2\(F +>.Y5L"Z2C-0&5"@HR
MY@.@P8,VG)1X7"9I'!)HEMUE3Y19-ERDQ%I7%O2;B6:96^09*,.K@[>;R,_Z
M""XEN<#NDL.VD^>?RGJ:-(7VT,G!X%NH9%'[1$DB'..O.-^7FD2PFH3<(\MB
MY38!Y1-9:*D#_>D*\-O!QFQYJ!.Z18SQQTV,<2UCC#]N8HS?'1>X^]JJF&NK
M/(^=5F .3(_DMKH<E#@-4.EU*'I2ANI8Z2H9I=O1?D+CX:9(Q"H]<=":*4-!
M0CO@-E!2"E94FPD<\A/O,D^#P+C(=M&&ENO'"^VBD/P&'=J<BH!>E9_'I.21
MKU%! 7L[, 3%/$4?-4;[R ]AO*8,48\0:.0E(HW_O,C)16&_VC7(K/J(]K&L
MFHW:>-W.U45.#J L1JL!;(#\"E2'\B*9JS>W!!+$AU0 XQ8P0>WDCWQ:-5DJ
M_*8+)."MIJWN"RQQY:H.H<_.!QY659&,&;[VF!'C[" DPF<+)6HNH.C ;,C%
M_!D5>^U@-[,]TK,UUP(VQ^J42"W\^AQUL<D6*X7;5@4JT&"WV6F/&M5H;+('
MNQU4]\Q&TCXV+().>43W>7RS\6^(^XC;"'?8+T+A:+J4$+/MHHO&N*DH=B5G
MLF#E&\AJ#4^W(%-2"8CO=-?]"+#KA#$I6\W/:Q?=W"AOY>$+:^&E3UYLU9\8
MTO ^9*"8E%;(T[)WN<5BQL]4+K'F=EK0TV[,QXIT#S@B7 N3Z)<X&S[2D5:P
M))U*$_/C@.$)-?&%'98,T_P\7VB+-[5N"T(:AG8CZ[M::'7"=79GV%"ZUQ#M
M&Z@>5M9E]9$68\HX&31S/NUQ .5R@HCAXEQJ0:!DQJ7P)X'6BS #]6@XJ;1?
MIUBD<EX*C4%>.@#DE14?2RJY318B9JVWB9]4("@*=K1!MY^W?T.W5TU,[BZE
M&F!0>O7D@L:YJ4 FIE&D:%TBP\#&+])-C'U.)?K):!6\OBVP^;7EI<5 ,D [
MJ0MX]P &YOS1D6C>:857(KU'7>Y%CE66LGXIK%6L0AD&12RK!L37+VO#67?E
M-ZZ$.>\,8]!PXOM<6ZO\O6T<S://.'/Y:N!V!%%23HJX*5M#[1\U4*9$&7('
M-!:?^?D34HQ=E_!WL; *O^\+5K9-6/ZIA1U0U1#5>TEJB>:?-U G!C7GKE7V
MD>5VI@.\\!*U^J7($<H6(U5T BL13KA$M2Y^G71 #I7;NQ#J*"&KE)B;LR#'
M/5Z=&.X]<2#.OK-V6F.$U'D?P>S>D#_<AO<UZ5EMK!N+/!21]<:H=M59LQ8T
M,*8+N]M371AXF]<$V'.BB*<&*D6*_&ME9#8$#%>F)1.6A1G&,QGN1?BAUJ!W
M=1K;@$OLI)Z68RX#JM\/X=4%6EOR[@4<J0F^-E_ AE%\P T(421T5_U0T>3E
ML=1_4M630['83H#"F.!NYUKMTUI3*<'&%ZO1T;XK:#ETUDOH!&W<:V0UH;5J
M^4@KX63+@M00"4GC(%(7ZLC%&^C,E0=;PY<NHP!U3>^WGFO-[&RZ:0VVJ]4]
MNTDU0X+;U$4+ @[%GFUBUQ2R&VEB09FH;"K*I@UM[!T*#:Z^.%Y3E"L+0(O]
M$%::Z6JN:M> ZH7\9>N77_ZJUJ!A0_V>+!:)=@+9BDVPX[1^YO.-;"J:IDK7
MD_PNN6\^UL*,,F>IE#GF+$7Y\PV$3E-#V28FVNVL:L9[DX$2I%^BM"IS]KI]
M:&4'(&B_>!]6F[07<=H6>_5RU%LU2<&NR5'%7M"VH6ZYW J&F;5AHH-=MWPZ
MPC..+3 8*A%G3;5,/E?+IXS(U_OYV>O3#\=O2M@B_'^?0!VM%'>5@;BBRSM=
MLU7MABWK![ZOBH5J[91@QBD*$Q5JES"3R2-2H _PJP3V"EDP!C2K95O/B*;E
MI<33HJ#-=@CK=GJ>XY"C4GV_9;=:14I9H!:4)1D/F@@$)Z/&E]?MCABTQL(@
M;$PLL?\4!ZSJ<*+78BYK T98C+XF+!>G.ULFA4J"A%4'L9]R$V7K0',.IAZ5
MM\C\O6RP<*Q%X>VB(\@6/>'3E26,;K!&[J'.]5%$@N\T(D29(=K=^8*][Q@'
MC@O<WF"HVU^6@H'VC3ME/_#-^NJ1E9 C*RRV]A)*OX[8M#F=IXFJ1=[WE#!I
MG4Y%]L"JD!EXQJ8E E^JQ$<, 5"PGYM&QEGDA#ZZ'61"^%"$N&%*44.>8_V]
MI$Y<+7*WL+R%DH2=ZS]9M1F6?JERV!/U5A*5SFM[Q(T%;O8R3R(EIZ-\,0;-
MTX2)E,L:J6A0IF(_C6VU:.^KJ J8Y[QBY4VL-Y %Y ;%#+^BIJP,)'(RR6=C
M8,"E4VJ$A3SDQ<0,"\RQ*KDDI,2ST+_%X.4,,0Z:1J>,U<L^KP<AMX%@3#'O
MB1 <Q'?15ILB5I)\-PGG"69Y\:'R+04R;QPW1U5/H#7ID4ZJ;>BD'YMT8Y@/
M]GY&H:E_>2.5L,=A [+44)U:%$N])*J4JTU[EP)!KO\AM=1V^2CW'[>>KG(+
MSNNVRFJ#S6 &-5Z?VBN5H2"E=JVJJ@$S!;V!-1X92[5BXZ:WRB7:"LG5GH?'
M*DRTU>V@[FK:+W/ZJYL*Y*IK+U2?0$4E 9P9#;:^-ARR(<@SLAU5+-#Q5;&#
MRZ0XE8TM>-D#9G%%AP52KNMMJ#+?$V&)I-T;V#+A*.R$8580*F[KW\<-<NF:
M3ZDW!BG^KY/1Z>CDU]'>_SRJN3W"[;I%6MM/F[2VM4QK^VF3UK;A!'? N"=B
M?BW&)9VA2A"@@B,0X)A.7[9B8QC5IA6'26LT% =C/=,RW"QEN=LYI_+F@5++
M<X+*3[E52UO>!2D+3*]=8U=R*.I*2J8'CC=?U1"QYZC"VN8<NZ6&NI)7-"JE
M+4D:":DD=:VZ<CSL"KY?XV@U(CJHDL&$=5%;'0LG7* BBJQQ[UF9<\J]Y0TV
M\#16[^MZR>+$5-C+L)%",I$G+L*HVR'W[HT4>7Z+<=A3_@.HHNWZ>$_EVR#-
M1:2.ENVHL]1YI 6]DW8;GJ:$G1LXB?M-]HV.P>0*]B!4AP%AIL-/NI4//'C.
M01_C-2\" 0AOV9V<@6(RV3WOQ0,SNAT!:CZ/;7X"4[YEQ;^446 1?"VU0>]V
M]66,V="8.MJ0T& JW14.*ID(M/4-U$@&&\P8+&05!) 3RN$1"55W.]?F#?AW
MT'A._()=E[0FL@PH+\VV1T@Z:GS8'#OKD['KVX+==,YH=LW[X0W5-[6'JTDR
M%8QTB7&)Q_&2CJLZ%;(.%H NLF8ZJ;C#%"#'.*;LF52S\8YP;M1UNV)=Q6ZG
M\2YN[+LUGY+J+7(,HO($1>6>[0]E#6%O0=5W^@C5P(M=GVP--(MO8H2F?T'\
M::8:/5M>"97&Y/IG.><1Q'.,G,O1"42P60]0,Z@:+ZTGLMBNR&I19):[CRJ3
M38BN=QW,!LW!)9C1PDOE-/:3LP9&/<%ON3VE15*H%P51KN:8K#&=#FJ.DX$%
MH ]:/N[#.874!I0[R 6\UL<6*5(L:<%R]5W,*OL(.'H. 1II'<^XA-P^&W;B
M!#+E@7:42C)E6X> ZYBT39=.UL3:SA:I9 ,-6>^3#"ILN^2K1,&?T8A$H;MK
ME2CX,QI1"QM>K1)-5ZE$]:6_D;[3[=Q*X:DO[RI]QVRFY%34:&S5<E0*1TL9
M_1UI.0XI#3J.1J!J$Z=?0\=QB!)U NL$M(HCDKZMO,6-CURKYS0-YV@YM)/L
MJ3>9FLZO-&=HU7&85@T,\84J#U5OW%SG:38_-@D#:Z3=2'7?VT46A3.&;3@S
M<D\%H&\9=![HFC4=#V0PCW3)633J;R3Y,-<2U1O)'>7L84OXEA)187_(+*;(
M*F<TDU-5QRUME8J2<V@L$B)VF=K -'EQ@166 ?J"$A #Q1)E>1O--CEH20Z"
M-":9G283A$\9")($:QL*'6/ *9=+93%K;8[ 'E31#I<SED!'A8":F&PJV//.
M_#2G%<U/+R.&EV"O8^D=65_,@2G>4[MBSV]@8>9-B>I*X?X34#GEBDI6-GV$
M 7K.FZ\G^+KK3LUYE!+@ IJQ_+.$7DW42>,R8MY8FH,X48HRBR08+BD4$YXV
M:I<$ )5;3C!DM;KW$7>+-+D"%DTS5@K"+/AI^Z^4_HD/7.;<G!/$I:Y%FS#U
M*@G""XU3!/YVER.X]FYP=+ZN!(.&Y+4=A6=8E=>?M4>G^5;@GBW2,E=1<[/<
MM3V4),-VE44'1PFX4I6MT2VU]C&ZX=YQ1D/;<M)IO>UZ(E=9S&9<]6&L%)ZX
MOAO4'L<U&\:+$E,Z2B>B>WV!G;=#@]K^@+T"1LY3,G(,\VNT8?JJ=L6^=O@T
M%VK PU:A+HCVL6ACS8^+_5C6#G[P9\Y]T",+QS:C+*'3[3A2QW<=2V8SJX_:
M7=]>2%[3 )OZ&5#PWVI%Y;7":D5B-4Y>%Q36!0U-<@UJE&.Y31';>%PM\E9W
M4&&S5[>04X7AU]E'>,*;DF#%G=Z>ZW2-20=K8F?YF)10Y!!T3'STH;RH\;T$
M?172XQ*1GRXY$]OZE2  4("% RXA94:#3(X+54SM1AV&*2AYF,@"XUC/.<VG
M>*MIVYKT\):]X$PD.^?56J'6*@R#+[RJ0JWQJ*PDIGGKL;_UE^Y]O49*6VDN
M2F.M%L_.Z.IVO)0N;/N<P]R\'".5WJXGW+*!@=/DS0#,MCUNLJ!<-#SD]V5C
MWVIE];5?Q<8Z.Z!>TL4;$MJ 3N6.;R4THQ,H[:ECE?4N%5^ZRQ&5+P+7,>VW
MR9.&&A>R/A3),+7,=$)J&6^KV]F?KM2L,'M<*H\N<IJ$+LM>J3:Q\T$W6Z1Y
MM:YE16UMFWQ:/+QV5-5H:%W'2HU=&N'0ZEDRS1C9J&\AM+VKL-P)87OD25BN
MG'.@\</M,V1ZTPL'1,/'8VFG>I@1#>,VTD-40%!08KO\S+(/;)!O3P!+WV-[
M6=01%X!#F_R]?++@ />U/1B:ZB]>*/;CJ(A2DZ>U)WHY@?-Q5(>LG@F5'NK^
M[4UHU%:I#?&9RUHUK^:7B\RZ;!%<JV7_ABR70#/<)FG-./6M>/M:3V9OC+WP
MZFYI-<G?=0W'S8VI0[UX"571D.[IF(G:;]VXI#KI4H-QT-GTY!(E67.]#-;<
MDTO'UPI(*:DE_])*UN;0DTK >4A<BZ]-WTX&5YSFVJ@Z%_QJ0<YPQE_H25XI
M%V]V2@9\3&JMP1B37MS&C!7@#L</./W(O4"IN\8]!$&IPD^4*4Q.#;B3BZQR
MQ$6WH^7%BE6UK^1U-X!U??72510.[))-]E>V3$5'<+W%8) *#]0'?PXWO+*$
M8PPJ83Y+)H$U65O7,LH5@G!:BKBV[939NV+R?58 ]#5IXT@K;IMB!2"#=5FR
M:PMH36N5X*Q?*Q9,)(Y(I6)2"4\5"$@J0H3%=>R5.=LQTR*?<=F=U2);8AO7
M$]# ZALE2- L0$"WB8O"U$EW.R+LM#/++KREIXG+Q:$N-_270'8':_3T(8H)
MK90-//S2,4TM8%FER)$8=9QK7R \6Z:NI25'X00$K41;R.68W8[L+0;9R-1$
MD.%(U>@K,C@NMTD:6/,IW2++^.=-EO%:9AG_O,DRWG"".PBP33G MFL0LB1I
M:$BVI?G4%C&V(>6417$EE>XS@?I51;='X:FHSY[] )<(0V!4<(2*6"UEL@D
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MI_^[\T$>@LX/5N6*F'DLEL'QH+%^7^T"L085CBF&'S,@D1ZU7DKC5$G*8RJ
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MRR!:6+GDTA&3U4USB%BBZT,P-4TT&P^/.<H;WK;F4U+%^ S/I[![89,YSWE
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MM//W>O^-!D1 WF!W@Z7/<X8\;. 95KW.]WULUV.F:TK6]\@W'OIZWJ=RTL2
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M2F6BLY-NC<4%R5(S8"L)AT;L6@"M)6!(&;DN:8:L8PM;(JPIBM8Z(RFERTH
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MMYJVK4T)[]@+3C>R$]^M%>HLP3+8V^O*4UN/REIBVK>^W_O]>]\LD-0F6N)
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M/WW*\W!7O"^#38ECB7S]QZ'/%Q_Z?*_',IOT5\GASY3IKYG_"U!+ P04
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M>TEPFYWQM@<?V79!"/K 9 +A%8&TZKV,B?DA?6"IY/0F,FA4EMEN[QOXPR@
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MS T)QRXM1W,%W=81]^2YIX>DX9O36Y*4YS['1GLV*(/PS W(8(S'!9:2@9S
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M1MK!_P-02P$"% ,4    " #9@85;P<35C>(#   X#P  $0
M@ $     8WEC=2TR,#(U,3(P-"YX<V102P$"% ,4    " #9@85;:*V&=!<)
M   <:0  %0              @ $1!   8WEC=2TR,#(U,3(P-%]D968N>&UL
M4$L! A0#%     @ V8&%6UQ$W$XP#   3I$  !4              ( !6PT
M &-Y8W4M,C R-3$R,#1?;&%B+GAM;%!+ 0(4 Q0    ( -F!A5OYW9:/9 @
M +9C   5              "  ;X9  !C>6-U+3(P,C4Q,C T7W!R92YX;6Q0
M2P$"% ,4    " #9@85;_R4_ZGJ\   %>@0 "@              @ %5(@
M97@Q,"TQ+FAT;5!+ 0(4 Q0    ( -F!A5N:\9Y3K2H   SV   *
M      "  ??>  !E>#$P+3(N:'1M4$L! A0#%     @ V8&%6_V!24Z40P
M\,H!  D              ( !S D! &5X-"TQ+FAT;5!+ 0(4 Q0    ( -F!
MA5MUIOZ\JT<  )/1 0 )              "  8=- 0!E>#0M,BYH=&U02P$"
M% ,4    " #9@85;Y<;@X  -  #4/   "@              @ %9E0$ 97@Y
M.2TQ+FAT;5!+ 0(4 Q0    ( -F!A5OALLE#,@P  (<Y   *
M  "  8&B 0!E>#DY+3(N:'1M4$L! A0#%     @ V8&%6]8XF!!!'@  ,ML
M  L              ( !VZX! &9O<FTX+6LN:'1M4$L%!@     +  L CP(
' $7- 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CYCU="http://cycurion.com/20251204"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cycu-20251204.xsd" xlink:type="simple"/>
    <context id="AsOf2025-12-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
        </entity>
        <period>
            <startDate>2025-12-04</startDate>
            <endDate>2025-12-04</endDate>
        </period>
    </context>
    <context id="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-04</startDate>
            <endDate>2025-12-04</endDate>
        </period>
    </context>
    <context id="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868419</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CYCU:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-04</startDate>
            <endDate>2025-12-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-12-04" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-04" id="Fact000004">0001868419</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-12-04" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-12-04" id="Fact000010">2025-12-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-04" id="Fact000011">CYCURION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-12-04" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-12-04" id="Fact000013">001-41214</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-12-04" id="Fact000014">86-3720717</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-12-04" id="Fact000015">1640     Boro Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-12-04" id="Fact000016">Suite 420C</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-12-04" id="Fact000017">McLean</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-12-04" id="Fact000018">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-12-04" id="Fact000019">22102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-12-04" id="Fact000020">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-12-04" id="Fact000021">740-0710</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-12-04" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-12-04" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-12-04" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-12-04" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000026">Common     stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">CYCU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-12-042025-12-04_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"
      id="Fact000029">Redeemable     warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"
      id="Fact000030">CYCUW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-12-042025-12-04_custom_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-12-04" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-12-04" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  04,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYCURION,
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001868419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-3720717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1640
    Boro Place<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 420C<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">McLean<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">22102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">740-0710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CYCU_CommonStockParValue0.0001PerShareMember', window );">Common stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember', window );">Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable
    warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCUW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CYCU_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CYCU_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cycurion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cycu-20251204.xsd</File>
    <File>cycu-20251204_def.xml</File>
    <File>cycu-20251204_lab.xml</File>
    <File>cycu-20251204_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>27
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "CYCU",
   "nsuri": "http://cycurion.com/20251204",
   "dts": {
    "schema": {
     "local": [
      "cycu-20251204.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cycu-20251204_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cycu-20251204_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cycu-20251204_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://cycurion.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "auth_ref": []
    },
    "CYCU_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cycurion.com/20251204",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "CYCU_RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cycurion.com/20251204",
     "localname": "RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cycurion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
